
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Gastroenterol</journal-id><journal-title-group><journal-title>BMC Gastroenterology</journal-title></journal-title-group><issn pub-type="epub">1471-230X</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">20875123</article-id><article-id pub-id-type="pmc">2955687</article-id><article-id pub-id-type="publisher-id">1471-230X-10-111</article-id><article-id pub-id-type="doi">10.1186/1471-230X-10-111</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Endoscopic treatments for Barrett's esophagus: a systematic review of safety and effectiveness compared to esophagectomy</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="A1"><name><surname>Menon</surname><given-names>Devidas</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>menon@ualberta.ca</email></contrib><contrib contrib-type="author" id="A2"><name><surname>Stafinski</surname><given-names>Tania</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>tanias@ualberta.ca</email></contrib><contrib contrib-type="author" id="A3"><name><surname>Wu</surname><given-names>Heng</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>heng2@ualberta.ca</email></contrib><contrib contrib-type="author" id="A4"><name><surname>Lau</surname><given-names>Darren</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>darren.lau@ualberta.ca</email></contrib><contrib contrib-type="author" id="A5"><name><surname>Wong</surname><given-names>Clarence</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>clarence.wong@ualberta.ca</email></contrib></contrib-group><aff id="I1"><label>1</label>Department of Public Health Sciences, University of Alberta, Room 3021, Research Transition Facility, 8308 114 Street, Edmonton, Alberta, T6G 2V2, Canada</aff><aff id="I2"><label>2</label>Department of Public Health Sciences, University of Alberta, 2-040 Health Research Innovation Facility East, 8602 112 Street, Edmonton, Alberta, T6G 2E1, Canada</aff><aff id="I3"><label>3</label>Division of Gastroenterology, University of Alberta, 331 Community Services Centre, Royal Alexandra Hospital, Edmonton, Alberta, T5H 3V9, Canada</aff><pub-date pub-type="collection"><year>2010</year></pub-date><pub-date pub-type="epub"><day>27</day><month>9</month><year>2010</year></pub-date><volume>10</volume><fpage>111</fpage><lpage>111</lpage><history><date date-type="received"><day>12</day><month>4</month><year>2010</year></date><date date-type="accepted"><day>27</day><month>9</month><year>2010</year></date></history><permissions><copyright-statement>Copyright &#x000a9;2010 Menon et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2010</copyright-year><copyright-holder>Menon et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0">http://creativecommons.org/licenses/by/2.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:href="http://www.biomedcentral.com/1471-230X/10/111"/><abstract><sec><title>Background</title><p>Recently, several new endoscopic treatments have been used to treat patients with Barrett's esophagus with high grade dysplasia. This systematic review aimed to determine the safety and effectiveness of these treatments compared with esophagectomy.</p></sec><sec><title>Methods</title><p>A comprehensive literature search was undertaken to identify studies of endoscopic treatments for Barrett's esophagus or early stage esophageal cancer. Information from the selected studies was extracted by two independent reviewers. Study quality was assessed and information was tabulated to identify trends or patterns. Results were pooled across studies for each outcome. Safety (occurrence of adverse events) and effectiveness (complete eradication of dysplasia) were compared across different treatments.</p></sec><sec><title>Results</title><p>The 101 studies that met the selection criteria included 8 endoscopic techniques and esophagectomy; only 12 were comparative studies. The quality of evidence was generally low. Methods and outcomes were inconsistently reported. Protocols, outcomes measured, follow-up times and numbers of treatment sessions varied, making it difficult to calculate pooled estimates.</p><p>The surgical mortality rate was 1.2%, compared to 0.04% in 2831 patients treated endoscopically (1 death). Adverse events were more severe and frequent with esophagectomy, and included anastomotic leaks (9.4%), wound infections (4.1%) and pulmonary complications (4.1%). Four patients (0.1%) treated endoscopically experienced bleeding requiring transfusions. The stricture rate with esophagectomy (5.3%) was lower than with porfimer sodium photodynamic therapy (18.5%), but higher than aminolevulinic acid (ALA) 60 mg/kg PDT (1.4%). Dysphagia and odynophagia varied in frequency across modalities, with the highest rates reported for multipolar electrocoagulation (MPEC). Photosensitivity, an adverse event that occurs only with photodynamic therapy, was experienced by 26.4% of patients who received porfimer sodium.</p><p>Some radiofrequency ablation (RFA) or argon plasma coagulation (APC) studies (used in multiple sessions) reported rates of almost 100% for complete eradication of dysplasia. But the study methods and findings were not adequately described. The other studies of endoscopic treatments reported similarly high rates of complete eradication.</p></sec><sec><title>Conclusions</title><p>Endoscopic treatments offer safe and effective alternatives to esophagectomy for patients with Barrett's esophagus and high grade dysplasia. Unfortunately, shortcomings in the published studies make it impossible to determine the comparative effectiveness of each of the endoscopic treatments.</p></sec></abstract></article-meta></front><body><sec><title>Background</title><p>Barrett's esophagus (BE) is a benign condition where abnormal cells (intestinal metaplasia), replace the normal lining of the esophagus. It is typically caused by long-term gastroesophageal reflux disease. Between 2% to 6% of Canadians may have Barrett's esophagus[<xref ref-type="bibr" rid="B1">1</xref>]. Similar prevalence rates have been reported in studies from Sweden (1.6%) and the United States (5.9%)[<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B3">3</xref>].</p><p>Although Barrett's esophagus itself is not harmful, in some individuals, precancerous dysplasia develops in the Barrett's tissue. The presence of dysplasia carries a higher risk of developing esophageal adenocarcinoma - a type of esophageal cancer. In addition to the cancer risk, Barrett's esophagus decreases patients' quality of life and increases health care costs[<xref ref-type="bibr" rid="B4">4</xref>-<xref ref-type="bibr" rid="B7">7</xref>].</p><p>The rising incidence of esophageal adenocarcinoma has focused attention on preventing cancer by removing the dysplasia and allowing normal, squamous esophageal mucosa to regenerate. Endoscopic techniques have been developed as a result. They can be applied sequentially to increase diagnostic yield and improve treatment outcomes. There are two categories: endoscopic mucosal resection (EMR) and endoscopic ablation. EMR with a cautery snare excision technique can remove visible raised or flat lesions for diagnostic and therapeutic roles. Diagnostically, it allows for complete histopathological assessment of the target mucosa. Those with superficial lesions can go on to further ablative techniques. Lesions that are found to invade submucosa may need referral for surgical resection. Therapeutically, EMR can be used for curative intent if the target lesion is small. However, in most cases of Barrett's esophagus, it is used to remove dysplastic nodules leaving the larger surface area for endoscopic ablation.</p><p>Photodynamic therapy (PDT) is one of the new endoscopic treatments used to remove dysplasia. Other endoscopic treatments include: argon plasma coagulation (APC), cryoablation, laser ablation, multipolar electrocoagulation (MPEC), radiofrequency ablation (RFA), and thermocoagulation. Depending on the extent of dysplasia, several endoscopic treatment sessions or a combination of treatments may be used.</p><p>Patients also receive long-term drug therapy to control gastroesophageal reflux and prevent further damage to the esophagus[<xref ref-type="bibr" rid="B8">8</xref>]. Endoscopic therapies are less invasive alternatives to esophagectomy (surgical removal of the esophagus), which is associated with high rates of morbidity and mortality, and with decreased quality of life[<xref ref-type="bibr" rid="B9">9</xref>-<xref ref-type="bibr" rid="B11">11</xref>].</p><p>Clinicians now have a variety of technologies to choose from when treating Barrett's esophagus with dysplasia. This systematic review of published clinical studies compares the evidence on the safety and effectiveness of the endoscopic treatments and of esophagectomy and may provide some guidance for clinical practice.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Data collection</title><sec><title>Literature search</title><p>An extensive search for published and unpublished studies of endoscopic and non-endoscopic procedures for Barrett's esophagus was performed. Search terms included keywords and controlled vocabulary terms used to describe Barrett's, photodynamic therapy and other endoscopic techniques, and esophagectomy. Searches for the alternative treatments (i.e., other than PDT) were limited to studies from 2003 to January 2009. The bibliographic databases searched included: PubMed (MEDLINE), The Cochrane Library, the UK Centre for Reviews and Dissemination (DARE, Health Technology Assessment, and NHS Economic Evaluation) databases, EMBASE, CINAHL, Web of Science and EconLit. Monthly update searches in PubMed were run throughout the project to identify new studies. Meeting abstracts from the American Society of Clinical Oncology and Digestive Disease Week, as well as practice guidelines and clinical trials web sites were also searched, as were the reference lists from relevant papers and earlier health technology assessments.</p></sec><sec><title>Study selection</title><p>Results from the literature searches were imported into a Reference Manager<sup>&#x000ae; </sup>database to remove duplicates and manage bibliographic citations. Titles and abstracts (where available), were independently screened by two researchers. The full papers of potentially relevant studies were retrieved and assessed against pre-defined inclusion criteria (Table <xref ref-type="table" rid="T1">1</xref>). Non-English language studies were excluded, unless an English language abstract provided sufficient detail on patients and outcomes.</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Criteria for including studies in this review</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Parameter</th><th align="center">Inclusion criteria</th><th align="center">Exclusion criteria</th></tr></thead><tbody><tr><td/><td align="left">&#x02022; Randomized or controlled (e.g., pseudo-randomized or quasi-randomized) trials</td><td/></tr><tr><td align="left"><italic>Study design</italic></td><td align="left">&#x02022; Non-randomized clinical trials</td><td align="left">&#x02022; Editorials &#x00026; opinion pieces</td></tr><tr><td/><td align="left">&#x02022; Retrospective, prospective, or concurrent cohort studies</td><td align="left">&#x02022; Review articles</td></tr><tr><td/><td align="left">&#x02022; Case or clinical series</td><td/></tr><tr><td align="left"><italic>Participants</italic></td><td align="left">&#x02022; Patients diagnosed with BE</td><td align="left">&#x02022; Patients diagnosed with esophageal cancer or other conditions</td></tr><tr><td/><td align="left">&#x02022; PDT</td><td/></tr><tr><td align="left"><italic>Interventions</italic></td><td align="left">&#x02022; Esophagectomy</td><td/></tr><tr><td/><td align="left">&#x02022; EMR</td><td/></tr><tr><td/><td align="left">&#x02022; Other endoscopic treatments (cryoablation, laser ablation, APC, MPEC, RFA, thermocoagulation)</td><td/></tr><tr><td align="left"><italic>Comparators</italic></td><td align="left">&#x02022; Same as interventions above</td><td/></tr><tr><td align="left"><italic>Outcomes</italic></td><td align="left">&#x02022; Not used for inclusion/exclusion due to heterogeneity of data</td><td/></tr></tbody></table></table-wrap></sec><sec><title>Critical appraisal and synthesis</title><p>Information from the studies was extracted by two reviewers using a pre-tested data abstraction form and a set of decision rules. The form contained elements for examining the purpose and methods of each study (Table <xref ref-type="table" rid="T2">2</xref>). Missing data were sought from study authors. Consensus between reviewers on the information collected was assessed using the Kappa statistic.</p><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Summary of elements in the data abstraction form</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Parameter</th><th align="left">Description of information collected</th></tr></thead><tbody><tr><td align="left"><italic>Cancer/cell type</italic></td><td align="left">BE; dysplasia</td></tr><tr><td align="left"><italic>Study design</italic></td><td align="left">Setting; study type; treatment(s) used; length of follow-up</td></tr><tr><td align="left"><italic>Patients</italic></td><td align="left">Number of patients by treatment group; age; gender; length of Barrett's; inclusion<italic>/</italic>exclusion criteria; prior treatments</td></tr><tr><td align="left"><italic>Intervention</italic></td><td align="left">Details of the treatment; number of patients who underwent each treatment; co-interventions</td></tr><tr><td align="left"><italic>Outcomes</italic></td><td align="left">Complete and partial response; survival; recurrence; progression to cancer; reduction in length of Barrett's; adverse events</td></tr></tbody></table></table-wrap><p>The quality of each study was also assessed by two reviewers using the Oxford Centre for Evidence-based Medicine Levels of Evidence[<xref ref-type="bibr" rid="B12">12</xref>]. Discrepancies were resolved through consensus and Kappa scores were calculated.</p></sec></sec><sec><title>Data analysis</title><sec><title>Qualitative</title><p>Information was summarized in tabular form to more easily identify trends or patterns in findings reported across studies.</p></sec><sec><title>Quantitative</title><p>Results from individual studies were pooled using weighted mean values to generate summary estimates for each of the outcomes of interest. All quantitative analyses were conducted in accordance with intention-to-treat principles (i.e., patients were analyzed in the groups to which they were originally allocated, regardless of whether or not they received the assigned treatment).</p></sec></sec></sec><sec><title>Results</title><sec><title>Description of studies</title><p>Over 400 potentially relevant papers were selected from the literature search results and reviewed for inclusion (Figure <xref ref-type="fig" rid="F1">1</xref>). Of these, 99 papers, reporting on 101 separate studies and 3042 patients, met the inclusion criteria. Descriptions of each study are presented in Additional files <xref ref-type="supplementary-material" rid="S1">1</xref>, <xref ref-type="supplementary-material" rid="S2">2</xref>, <xref ref-type="supplementary-material" rid="S3">3</xref>, <xref ref-type="supplementary-material" rid="S4">4</xref>, <xref ref-type="supplementary-material" rid="S5">5</xref>, <xref ref-type="supplementary-material" rid="S6">6</xref>, <xref ref-type="supplementary-material" rid="S7">7</xref>, and <xref ref-type="supplementary-material" rid="S8">8</xref>. A breakdown of studies by the type of intervention and study design is presented in Table <xref ref-type="table" rid="T3">3</xref>.</p><fig id="F1" position="float"><label>Figure 1</label><caption><p><bold>Flow diagram of study selection</bold>. <bold><italic>Notes: </italic></bold>*10 new studies were added since the first literature review. Of these studies, 6 were included, and 4 were excluded.</p></caption><graphic xlink:href="1471-230X-10-111-1"/></fig><table-wrap id="T3" position="float"><label>Table 3</label><caption><p>Numbers of included studies and patients</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th align="center">Treatment</th><th align="center">Number of studies</th><th align="center">Comparative studies</th><th align="center">Non-comparative studies</th><th align="center">Number of patients</th></tr></thead><tbody><tr><td align="left"><bold>Endoscopic</bold></td><td align="left">PDT</td><td align="center">37</td><td align="center">5[<xref ref-type="bibr" rid="B13">13</xref>-<xref ref-type="bibr" rid="B16">16</xref>,<xref ref-type="bibr" rid="B25">25</xref>]</td><td align="center">32[<xref ref-type="bibr" rid="B22">22</xref>,<xref ref-type="bibr" rid="B26">26</xref>-<xref ref-type="bibr" rid="B54">54</xref>]</td><td align="center">1028</td></tr><tr><td/><td align="left">APC</td><td align="center">26</td><td align="center">7[<xref ref-type="bibr" rid="B13">13</xref>-<xref ref-type="bibr" rid="B18">18</xref>,<xref ref-type="bibr" rid="B55">55</xref>]</td><td align="center">19[<xref ref-type="bibr" rid="B23">23</xref>,<xref ref-type="bibr" rid="B56">56</xref>-<xref ref-type="bibr" rid="B73">73</xref>]</td><td align="center">792</td></tr><tr><td/><td align="left">Cryoablation</td><td align="center">2</td><td align="center">0</td><td align="center">2[<xref ref-type="bibr" rid="B74">74</xref>,<xref ref-type="bibr" rid="B75">75</xref>]</td><td align="center">31</td></tr><tr><td/><td align="left">Combined EMR &#x00026; PDT</td><td align="center">2</td><td align="center">1[<xref ref-type="bibr" rid="B25">25</xref>]</td><td align="center">1[<xref ref-type="bibr" rid="B76">76</xref>]</td><td align="center">6</td></tr><tr><td/><td align="left">Thermocoagulation</td><td align="center">1</td><td align="center">0</td><td align="center">1[<xref ref-type="bibr" rid="B77">77</xref>]</td><td align="center">13</td></tr><tr><td/><td align="left">EMR</td><td align="center">6</td><td align="center">2[<xref ref-type="bibr" rid="B20">20</xref>,<xref ref-type="bibr" rid="B25">25</xref>]</td><td align="center">4[<xref ref-type="bibr" rid="B78">78</xref>-<xref ref-type="bibr" rid="B81">81</xref>]</td><td align="center">38</td></tr><tr><td/><td align="left">Laser ablation</td><td align="center">7</td><td align="center">0</td><td align="center">7[<xref ref-type="bibr" rid="B24">24</xref>,<xref ref-type="bibr" rid="B82">82</xref>-<xref ref-type="bibr" rid="B87">87</xref>]</td><td align="center">91</td></tr><tr><td/><td align="left">MPEC</td><td align="center">6</td><td align="center">2[<xref ref-type="bibr" rid="B17">17</xref>,<xref ref-type="bibr" rid="B18">18</xref>]</td><td align="center">4[<xref ref-type="bibr" rid="B88">88</xref>-<xref ref-type="bibr" rid="B90">90</xref>]</td><td align="center">118</td></tr><tr><td/><td align="left">RFA</td><td align="center">16</td><td align="center">2[<xref ref-type="bibr" rid="B19">19</xref>,<xref ref-type="bibr" rid="B92">92</xref>]</td><td align="center">14[<xref ref-type="bibr" rid="B93">93</xref>-<xref ref-type="bibr" rid="B105">105</xref>]</td><td align="center">714</td></tr><tr><td/><td align="left">Total*</td><td align="center">95*</td><td align="center">11*</td><td align="center">86</td><td align="center">2831</td></tr><tr><td align="left"><bold>Surgical</bold></td><td align="left">Esophagectomy</td><td align="center">8</td><td align="center">3[<xref ref-type="bibr" rid="B21">21</xref>,<xref ref-type="bibr" rid="B57">57</xref>,<xref ref-type="bibr" rid="B79">79</xref>]</td><td align="center">5[<xref ref-type="bibr" rid="B109">109</xref>-<xref ref-type="bibr" rid="B111">111</xref>]112</td><td align="center">211</td></tr><tr><td colspan="6"><hr/></td></tr><tr><td align="left"><bold>Total*</bold></td><td/><td align="center">101*</td><td align="center">12*</td><td align="center">91</td><td align="center">3042</td></tr></tbody></table><table-wrap-foot><p><bold><italic>Notes: </italic></bold>(1) APC (argon plasma coagulation), EMR (endoscopic mucosal resection), MPEC (multipolar electrocoagulation), PDT (photodynamic therapy), RFA (radiofrequency ablation) (2) *9 comparative studies are reported in both intervention groups (e.g., APC and PDT), thus the number of separate comparative trials is less than the sum of entries in the column.</p></table-wrap-foot></table-wrap></sec><sec><title>Quality of studies</title><p>The quality of the evidence reviewed was generally low. Only 12 studies were comparative (Table <xref ref-type="table" rid="T3">3</xref>), and of these, 5 were cohort studies with uncontrolled allocation of patients to each treatment group. Details of the study methods used were sparse, with missing information or inconsistent reporting of outcomes across patient groups.</p><p>Seven randomized controlled trials (RCTs) were identified, but these compared only APC with PDT (4 trials[<xref ref-type="bibr" rid="B13">13</xref>-<xref ref-type="bibr" rid="B16">16</xref>]), or APC with MPEC (2 trials[<xref ref-type="bibr" rid="B17">17</xref>,<xref ref-type="bibr" rid="B18">18</xref>]), or RFA with sham procedure (1 trial[<xref ref-type="bibr" rid="B19">19</xref>]). Sample sizes were small and follow-up times were short. Because the types of patients and the treatment protocols (e.g., number of treatment sessions) varied a meta-analysis was not used.</p><p>In the non-comparative studies of endoscopic techniques (single arm clinical trials or case series), the treatment protocols (e.g., number of treatment sessions), outcomes measured, and follow-up times also differed. There were few studies that reported long-term follow up results, and so pooling of study outcome and adverse event results is limited. As well, the number of treatment sessions provided before outcomes were measured was not often reported, although in many cases, it was after a single ablation. Patients often received interventions in addition to the study treatment. For example, in most studies EMR was performed during endoscopy to confirm the diagnosis of dysplasia. In addition, if one treatment failed to eradicate the dysplasia another treatment would typically be administered. The analyses of outcomes did not usually account for the effects of these additional interventions.</p></sec><sec><title>Safety</title><p>Adverse events reported for individual studies of esophagectomy and endoscopic alternatives are summarized in Table <xref ref-type="table" rid="T4">4</xref> and Additional file <xref ref-type="supplementary-material" rid="S9">9</xref>. The pooled estimates for esophagectomy and endoscopic treatments are shown in Tables <xref ref-type="table" rid="T5">5</xref> and <xref ref-type="table" rid="T6">6</xref>. There were 2 deaths [<xref ref-type="bibr" rid="B20">20</xref>,<xref ref-type="bibr" rid="B21">21</xref>] attributed to esophagectomy among the 170 patients who underwent the procedure (a mortality rate of 1.2%). (The surgical studies employed various approaches; in some studies, the actual approach was not specified, and in the others, a number of approaches were used (i.e., the patients did not all have the same surgical approach). Therefore, data could not be analysed according to individual surgical approaches). In contrast, 1 death [<xref ref-type="bibr" rid="B13">13</xref>] was reported in the 2831 patients who received endoscopic treatment (0.04%). This death was due to cardiac arrhythmia in a patient who received PDT with aminolevulinic acid (ALA) at a dose of 60 mg/kg of body weight[<xref ref-type="bibr" rid="B13">13</xref>].</p><table-wrap id="T4" position="float"><label>Table 4</label><caption><p>Studies of adverse events post-esophagectomy</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th/><th align="left" colspan="10">Adverse event rates (No. of patients who suffered adverse events/No. of patients who received esophagectomy)</th></tr></thead><tbody><tr><td align="center"><bold>Study</bold></td><td align="center"><bold>No. of patients</bold></td><td align="center"><bold>A.leak*</bold></td><td align="center"><bold>CV compl.*</bold></td><td align="center"><bold>Del. gastric emptying*</bold></td><td align="center"><bold>Mortality</bold></td><td align="center"><bold>Pneumon.*</bold></td><td align="center"><bold>Pulm. compl.*</bold></td><td align="center"><bold>Pulm. embol.*</bold></td><td align="center"><bold>Small bowel perf.*</bold></td><td align="center"><bold>Strictures</bold></td><td align="center"><bold>Wound infec.*</bold></td></tr><tr><td colspan="12"><hr/></td></tr><tr><td align="left" colspan="12"><italic>Comparative studies</italic></td></tr><tr><td align="center">Prasad GA, et al. (2007)[<xref ref-type="bibr" rid="B21">21</xref>]</td><td align="center">70</td><td align="center">0% (0/70)</td><td align="center">0% (0/70)</td><td align="center">0% (0/70)</td><td align="center">1.4% (1/70)</td><td align="center">0% (0/70)</td><td align="center">0% (0/70)</td><td align="center">0% (0/70)</td><td align="center">0% (0/70)</td><td align="center">12.9% (9/70)</td><td align="center">0% (0/70)</td></tr><tr><td align="center">Reed MF, et al. (2005)[<xref ref-type="bibr" rid="B20">20</xref>]</td><td align="center">49</td><td align="center">4.1% (2/49)</td><td align="center">0% (0/49)</td><td align="center">0% (0/49)</td><td align="center">2.0% (1/49)</td><td align="center">0% (0/49)</td><td align="center">0% (0/49)</td><td align="center">0% (0/49)</td><td align="center">0% (0/49)</td><td align="center">0% (0/49)</td><td align="center">0% (0/49)</td></tr><tr><td align="center">Thomas T, et al. (2005)[<xref ref-type="bibr" rid="B55">55</xref>]</td><td align="center">8</td><td align="center">Not reported</td><td align="center">Not reported</td><td align="center">Not reported</td><td align="center">Not reported</td><td align="center">Not reported</td><td align="center">Not reported</td><td align="center">Not reported</td><td align="center">Not reported</td><td align="center">Not reported</td><td align="center">Not reported</td></tr><tr><td align="left" colspan="12"><italic>Non-comparative studies</italic></td></tr><tr><td align="center">Ferguson MK, et al. (1997)[<xref ref-type="bibr" rid="B107">107</xref>]</td><td align="center">15</td><td align="center">73.3% (11/15)</td><td align="center">20.0% (3/15)</td><td align="center">0% (0/15)</td><td align="center">0% (0/15)</td><td align="center">0% (0/15)</td><td align="center">26.7% (4/15)</td><td align="center">0% (0/15)</td><td align="center">0% (0/15)</td><td align="center">0% (0/15)</td><td align="center">33.3% (5/15)</td></tr><tr><td align="center">Nguyen NT, et al. (2000)[<xref ref-type="bibr" rid="B108">108</xref>]</td><td align="center">12</td><td align="center">0% (0/12)</td><td align="center">0% (0/12)</td><td align="center">25.0% (3/12)</td><td align="center">0% (0/12)</td><td align="center">0% (0/12)</td><td align="center">16.7% (2/12)</td><td align="center">0% (0/12)</td><td align="center">8.3% (1/12)</td><td align="center">0% (0/12)</td><td align="center">8.3% (1/12)</td></tr><tr><td align="center">Romagnoli R (2003)[<xref ref-type="bibr" rid="B109">109</xref>]</td><td align="center">33</td><td align="center">Not reported</td><td align="center">Not reported</td><td align="center">Not reported</td><td align="center">Not reported</td><td align="center">Not reported</td><td align="center">Not reported</td><td align="center">Not reported</td><td align="center">Not reported</td><td align="center">Not reported</td><td align="center">Not reported</td></tr><tr><td align="center">Sujendran V, et al. (2005)[<xref ref-type="bibr" rid="B110">110</xref>]</td><td align="center">17</td><td align="center">17.6% (3/17)</td><td align="center">0% (0/17)</td><td align="center">0% (0/17)</td><td align="center">0% (0/17)</td><td align="center">17.6% (3/17)</td><td align="center">5.9% (1/17)</td><td align="center">0% (0/17)</td><td align="center">0% (0/17)</td><td align="center">0% (0/17)</td><td align="center">0% (0/17)</td></tr><tr><td align="center">Thomson BNJ &#x00026; Cade RJ (2003)[<xref ref-type="bibr" rid="B111">111</xref>]</td><td align="center">7</td><td align="center">0% (0/7)</td><td align="center">0% (0/7)</td><td align="center">0% (0/7)</td><td align="center">0% (0/7)</td><td align="center">0% (0/7)</td><td align="center">0% (0/7)</td><td align="center">14.3% (1/7)</td><td align="center">0% (0/7)</td><td align="center">0% (0/7)</td><td align="center">14.3% (1/7)</td></tr><tr><td align="center">Pooled total</td><td align="center">211</td><td align="center">9.4% (16/170) 0-73.3%&#x02021;</td><td align="center">1.8% (3/170) 0-20.0%&#x02021;</td><td align="center">1.8% (3/170) 0-25.0%&#x02021;</td><td align="center">1.2% (2/170) 0-2.0%&#x02021;</td><td align="center">1.8% (3/170) 0-17.6%&#x02021;</td><td align="center">4.1% (7/170) 0-26.7%&#x02021;</td><td align="center">0.6% (1/170) 0-14.3%&#x02021;</td><td align="center">0.6% (1/170) 0-8.3%&#x02021;</td><td align="center">5.3% (9/170) 0-12.9%&#x02021;</td><td align="center">4.1% (7/170) 0-33.3%&#x02021;</td></tr></tbody></table><table-wrap-foot><p><bold><italic>Notes: </italic></bold>(1) *A.leak (anastomotic leak), CV compl. (cardiovascular complication), Del. gastric emptying (delayed gastric emptying), Pneumon. (pneumonia), Pulm. compl. (pulmonary complication), Pulm. embol. (pulmonary embolsim), Small bowel perf. (small bowel perforation), Wound infec. (wound infection) (2) &#x02021;Ranges of the adverse event rates post-esophagectomy for the included studies</p></table-wrap-foot></table-wrap><table-wrap id="T5" position="float"><label>Table 5</label><caption><p>Summary of adverse events post-esophagectomy</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center">A. leak*</th><th align="center">CV compl.*</th><th align="center">Del. gastric emptying*</th><th align="center">Mortality</th><th align="center">Pneumon.*</th><th align="center">Pulm. compl.*</th><th align="center">Pulm. embol.*</th><th align="center">Small bowel perf.*</th><th align="center">Strictures</th><th align="center">Wound infec.*</th></tr></thead><tbody><tr><td align="center">9.4%&#x0066d;</td><td align="center">1.8%&#x0066d;</td><td align="center">1.8%&#x0066d;</td><td align="center">1.2%&#x0066d;</td><td align="center">1.8%&#x0066d;</td><td align="center">4.1%&#x0066d;</td><td align="center">0.6%&#x0066d;</td><td align="center">0.6%&#x0066d;</td><td align="center">5.3%&#x0066d;</td><td align="center">4.1%&#x0066d;</td></tr><tr><td align="center">16/170&#x02021;</td><td align="center">3/170&#x02021;</td><td align="center">3/170&#x02021;</td><td align="center">2/170&#x02021;</td><td align="center">3/170&#x02021;</td><td align="center">7/170&#x02021;</td><td align="center">1/170&#x02021;</td><td align="center">1/170&#x02021;</td><td align="center">9/170&#x02021;</td><td align="center">7/170&#x02021;</td></tr><tr><td align="center">0 -73.3%&#x02020;</td><td align="center">0 -20.0%&#x02020;</td><td align="center">0 - 25.0%&#x02020;</td><td align="center">0 - 2.0%&#x02020;</td><td align="center">0 - 17.6%&#x02020;</td><td align="center">0 - 26.7%&#x02020;</td><td align="center">0 - 14.3%&#x02020;</td><td align="center">0 - 8.3%&#x02020;</td><td align="center">0 - 12.9%&#x02020;</td><td align="center">0 - 33.3%&#x02020;</td></tr></tbody></table><table-wrap-foot><p><bold><italic>Notes: </italic></bold>(1) *A.leak (anastomotic leak), CV compl. (cardiovascular complication), Del. gastric emptying (delayed gastric emptying), Pneumon. (pneumonia), Pulm. compl. (pulmonary complication), Pulm. embol. (pulmonary embolism), Small bowel perf. (small bowel perforation), Wound infec. (wound infection) (2) &#x0066d;Adverse event rates post-esophagectomy, &#x02021; No. of patients who suffered adverse events/No. of patients who received esophagectomy, &#x02020; Ranges of the adverse event rates post-esophagectomy for the included studies</p></table-wrap-foot></table-wrap><p>In the studies that reported bleeding complications following endoscopic treatments, 4 of 2218 patients (0.2%) experienced bleeding requiring transfusions: 1 after PDT[<xref ref-type="bibr" rid="B22">22</xref>], 2 after APC[<xref ref-type="bibr" rid="B23">23</xref>] and 1 after laser ablation[<xref ref-type="bibr" rid="B24">24</xref>]. Strictures were most frequently reported with porfimer sodium PDT (18.5%), followed by laser ablation (4.4%) and APC (2.9%) (Table <xref ref-type="table" rid="T6">6</xref>). Although there were no perforations reported in the PDT studies that used a single photosensitizer (reported in Table <xref ref-type="table" rid="T6">6</xref>), there was a perforation reported in the Prasad et al study [<xref ref-type="bibr" rid="B21">21</xref>], which compared esophagectomy with PDT using two different photosensitizers. Since it was impossible to separate the patients according to the photosensitizer type, this study was not included in Table <xref ref-type="table" rid="T6">6</xref>. Patients experiencing dysphagia and odynophagia varied across the treatment modalities, but were highest with MPEC (Table <xref ref-type="table" rid="T6">6</xref>). Photosensitivity following PDT was more common with porfimer sodium (26.4%) than with ALA (ranging from 0% to 13.6%). However, in a small series of 5 patients who received hematoporphyrin derivative (HpD), 40% experienced photosensitivity reactions (Table <xref ref-type="table" rid="T6">6</xref>).</p><table-wrap id="T6" position="float"><label>Table 6</label><caption><p>Summary of adverse events post-endoscopic treatments</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th align="center" colspan="6">Adverse event rates post- endoscopic treatments (No. of patients who suffered adverse events/No. of patients who received treatments)</th></tr></thead><tbody><tr><td align="left"><bold>Study</bold></td><td align="center"><bold>Dysphagia</bold></td><td align="center"><bold>Photosen.*</bold></td><td align="center"><bold>Stricture</bold></td><td align="center"><bold>Perfor.*</bold></td><td align="center"><bold>Odynoph.*</bold></td><td align="center"><bold>Bleed.*</bold></td></tr><tr><td colspan="7"><hr/></td></tr><tr><td align="center" colspan="7"><bold><italic>PDT</italic></bold></td></tr><tr><td align="left"><bold>ALA 15 mg/kg</bold></td><td align="center">15.4% (2/13)</td><td align="center">13.6% (3/22) 0-23.1%&#x02020;</td><td align="center">0% (0/22)</td><td align="center">0% (0/22)</td><td align="center">0% (0/22)</td><td align="center">0% (0/22)</td></tr><tr><td align="left"><bold>ALA 30 mg/kg</bold></td><td align="center">0% (0/106)</td><td align="center">5.7% (6/106) 0-14.7%&#x02020;</td><td align="center">0% (0/106)</td><td align="center">0% (0/106)</td><td align="center">0.9% (1/106) 0-2.9%&#x02020;</td><td align="center">0%<sup>(4) </sup>(0/90)</td></tr><tr><td align="left"><bold>ALA 40 mg/kg</bold></td><td align="center">0% (0/22)</td><td align="center">0% (0/22)</td><td align="center">0% (0/22)</td><td align="center">0% (0/22)</td><td align="center">0% (0/22)</td><td align="center">0% (0/22)</td></tr><tr><td align="left"><bold>ALA</bold><sup><bold>(1) </bold></sup><bold>60 mg/kg</bold></td><td align="center">2.7% (4/148) 0-40.0%&#x02020;</td><td align="center">4.3% (6/140) 0-75.0%&#x02020;</td><td align="center">1.4% (2/148) 0-12.5%&#x02020;</td><td align="center">0% (0/148)</td><td align="center">16.2% (24/148) 0-92.3%&#x02020;</td><td align="center">0.9%<sup>(4) </sup>(1/115) 0-7.7%&#x02020;</td></tr><tr><td align="left"><bold>HpD 1.5 mg/kg</bold></td><td align="center">0% (0/59)</td><td align="center">40.0% (2/5)</td><td align="center">0% (0/59)</td><td align="center">0% (0/59)</td><td align="center">0% (0/5)</td><td align="center">0% (0/59)</td></tr><tr><td align="left"><bold>mTHPC 0.15 mg/kg</bold></td><td align="center">-**</td><td align="center">-**</td><td align="center">-**</td><td align="center">-**</td><td align="center">-**</td><td align="center">-**</td></tr><tr><td align="left"><bold>Porfimer sodium(2 mg/kg)</bold></td><td align="center">6.6% (26/394) 0-18.8%&#x02020;</td><td align="center">26.4% (104/394) 0-68.8%&#x02020;</td><td align="center">18.5% 73/394 0-37.5%&#x02020;</td><td align="center">0% (0/394)</td><td align="center">0% (0/394)</td><td align="center">0% (0/394)</td></tr><tr><td align="center" colspan="7"><bold><italic>Other endoscopic treatments</italic></bold></td></tr><tr><td align="left"><bold>APC</bold></td><td align="center">3.8% (27/719) 0-100%&#x02020;</td><td align="center">0% (0/719)</td><td align="center">2.9% (21/719) 0-23.1%&#x02020;</td><td align="center">0.3% (2/719) 0-3.4%&#x02020;</td><td align="center">11.8% (85/719) 0-94.1%&#x02020;</td><td align="center">0.4%<sup>(2) </sup>(3/719) 0-3.9%&#x02020;</td></tr><tr><td align="left"><bold>Cryoablation</bold></td><td align="center">9.1% (1/11)</td><td align="center">0% (0/11)</td><td align="center">0% (0/11)</td><td align="center">0% (0/11)</td><td align="center">0% (0/11)</td><td align="center">0% (0/11)</td></tr><tr><td align="left"><bold>Combined EMR &#x00026; PDT</bold></td><td align="center">0% (0/6)</td><td align="center">0% (0/6)</td><td align="center">0% (0/6)</td><td align="center">0% (0/6)</td><td align="center">0% (0/6)</td><td align="center">0% (0/6)</td></tr><tr><td align="left"><bold>Thermocoagualtion</bold></td><td align="center">0% (0/13)</td><td align="center">0% (0/13)</td><td align="center">0% (0/13)</td><td align="center">0% (0/13)</td><td align="center">0% (0/13)</td><td align="center">0% (0/13)</td></tr><tr><td align="left"><bold>EMR</bold></td><td align="center">0% (0/32)</td><td align="center">0% (0/32)</td><td align="center">0% (0/32)</td><td align="center">0% (0/32)</td><td align="center">0% (0/32)</td><td align="center">9.4% (3/32) 0-25.0%&#x02020;</td></tr><tr><td align="left"><bold>Laser ablation</bold></td><td align="center">0% (0/68)</td><td align="center">0% (0/68)</td><td align="center">4.4% (3/68) 0-12.5%&#x02020;</td><td align="center">1.5% (1/68) 0-4.8%&#x02020;</td><td align="center">0% (0/68)</td><td align="center">1.5%<sup>(5) </sup>(1/68) 0-4.8%&#x02020;</td></tr><tr><td align="left"><bold>MPEC</bold></td><td align="center">19.4% (18/93) 0-40.7%&#x02020;</td><td align="center">0% (0/93)</td><td align="center">1.1% (1/93) 0-3.7%&#x02020;</td><td align="center">0% (0/93)</td><td align="center">16.1% (15/93) 0-40.7%&#x02020;</td><td align="center">1.1% (1/93) 0-10.0%&#x02020;</td></tr><tr><td align="left"><bold>RFA</bold></td><td align="center">1.4% (8/574) 0-23.1%&#x02020;</td><td align="center">0% (0/574)</td><td align="center">1.9% (11/574) 0-6.1%&#x02020;</td><td align="center">0% (0/574)</td><td align="center">0.5% (3/574) 0-23.1%&#x02020;</td><td align="center">0.5% (3/574) 0-1.6%&#x02020;</td></tr></tbody></table><table-wrap-foot><p><bold><italic>Notes: </italic></bold>(1) 1 patient suffered cardiac arrhythmia resulting in sudden death [<xref ref-type="bibr" rid="B13">13</xref>]. (2) 2 patients required blood transfusions. (3) ALA (aminolevulinic acid), APC (argon plasma coagulation), EMR (endoscopic mucosal resection), HpD (hematoporphyrin derivative), MPEC (multipolar electrocoagulation), mTHPC (meta-tetrahydroxyphenylchlorin), PDT (photodynamic therapy), RFA (radiofrequency ablation) (4) 1 patient required blood transfusion, but it cannot be definitely attributed to the 30 mg/kg treatment or the 60 mg/kg ALA treatment. (5) 1 patient required blood transfusion. (6) * Photosen. (photosensitivity), Perfor. (perforation), Odynoph. (odynophagia), Bleed. (bleeding), ** - (pooled total not available), &#x02020; Ranges of the adverse event rates post-endoscopic treatments for the included studies</p></table-wrap-foot></table-wrap><p>The most commonly reported adverse events associated with esophagectomy were anastomotic leaks (9.4%), strictures (5.3%), wound infections (4.1%) and pulmonary complications (4.1%) (Table <xref ref-type="table" rid="T5">5</xref>). None of the studies discussed the relationship between adverse events and clinician experience.</p></sec><sec><title>Efficacy or effectiveness</title><p>Values reported for the complete eradication of BE or high grade dysplasia (HGD) with endoscopic treatments are presented in Additional files <xref ref-type="supplementary-material" rid="S10">10</xref> and <xref ref-type="supplementary-material" rid="S11">11</xref>. Pooled values for complete eradication of BE and HGD with endoscopic treatments are presented in Table <xref ref-type="table" rid="T7">7</xref>. For the purposes of this analysis, only the complete eradication rates reported in the individual studies within the first 3 months after ablation were included. Few studies provided enough data on longer follow up periods to make pooling of the data meaningful. The studies did not all report the number of ablations that were provided before the outcome was measured, and in many cases, the authors reported a range of number of treatments.</p><table-wrap id="T7" position="float"><label>Table 7</label><caption><p>Summary of complete eradication (CE) of BE and HGD post- endoscopic treatments</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Study</th><th align="center" colspan="2">CE rates of BE post -treatments (No. of patients who achieved CE of BE/No. of patients who received treatments)</th><th align="center" colspan="2">CE rates of HGD post -treatments (No. of patients who achieved CE of HGD/No. of patients who received treatments)</th></tr><tr><th/><th colspan="4"><hr/></th></tr><tr><th/><th align="center">Up to 3 months</th><th align="center">At 12 months</th><th align="center">Up to 3 months</th><th align="center">At 12 months</th></tr></thead><tbody><tr><td align="center" colspan="5"><bold><italic>PDT</italic></bold></td></tr><tr><td align="left"><bold>ALA 15 mg/kg</bold></td><td align="center">30.4% (7/23) 21.4-44.4%&#x02020;</td><td align="center">-**</td><td align="center">No studies of HGD</td><td align="center">No studies of HGD</td></tr><tr><td align="left"><bold>ALA 30 mg/kg</bold></td><td align="center">43.9% (18/41) 14.3-50.0%&#x02020;</td><td align="center">-**</td><td align="center">100% (4/4)</td><td align="center">-**</td></tr><tr><td align="left"><bold>ALA 40 mg/kg</bold></td><td align="center">0% (0/2)</td><td align="center">-**</td><td align="center">68.2% (15/22) 0-75.0%&#x02020;</td><td align="center">-**</td></tr><tr><td align="left"><bold>ALA 60 mg/kg</bold></td><td align="center">19.2% (5/26)</td><td align="center">-**</td><td align="center">96.6% (28/29) 96.3-100%&#x02020;</td><td align="center">-**</td></tr><tr><td align="left"><bold>HpD 1.5 mg/kg</bold></td><td align="center">0% (0/5)</td><td align="center">-**</td><td align="center">100% (1/1)</td><td align="center">100% (1/1)</td></tr><tr><td align="left"><bold>mTHPC 0.15 mg/kg</bold></td><td align="center">16.7% (1/6)</td><td align="center">-**</td><td align="center">66.7% (4/6)</td><td align="center">-**</td></tr><tr><td align="left"><bold>Porfimer sodium (2 mg/kg)</bold></td><td align="center">51.6% (94/182) 26.3-56.4%&#x02020;</td><td align="center">15.4% (2/13)</td><td align="center">77.5% (62/80)</td><td align="center">100% (2/2)</td></tr><tr><td align="center" colspan="5"><bold><italic>Other endoscopic treatments</italic></bold></td></tr><tr><td align="left"><bold>APC</bold></td><td align="center">85.5% (372/435) 0-100%&#x02020;</td><td align="center">64.9% (50/77) 0-93.8%&#x02020;</td><td align="center">85.7% (6/7)</td><td align="center">0% (0/0)</td></tr><tr><td align="left"><bold>Cryoablation</bold></td><td align="center">81.8% (9/11)</td><td align="center">63.6% (7/11)</td><td align="center">100% (1/1)</td><td align="center">-**</td></tr><tr><td align="left"><bold>Combined EMR &#x00026; PDT</bold></td><td align="center">-**</td><td align="center">-**</td><td align="center">66.7 (2/3)</td><td align="center">-**</td></tr><tr><td align="left"><bold>Thermocoagulation</bold></td><td align="center">100% (13/13)</td><td align="center">-**</td><td align="center">No studies of HGD</td><td align="center">No studies of HGD</td></tr><tr><td align="left"><bold>EMR</bold></td><td align="center">100% (1/1)</td><td align="center">-**</td><td align="center">96.3% (26/27) 92.9-100%&#x02020;</td><td align="center">83.3% (10/12)</td></tr><tr><td align="left"><bold>Laser ablation</bold></td><td align="center">77.3% (58/75) 22.2-100%&#x02020;</td><td align="center">-**</td><td align="center">-**</td><td align="center">-**</td></tr><tr><td align="left"><bold>MPEC</bold></td><td align="center">88.5% (23/26)</td><td align="center">100% (10/10)</td><td align="center">No studies of HGD</td><td align="center">No studies of HGD</td></tr><tr><td align="left"><bold>RFA</bold></td><td align="center">69.0% (118/171) 21.9-97.7%&#x02020;</td><td align="center">72.3% (170/235) 46.2%-92.6%&#x02020;</td><td align="center">90.3% (93/103) 90.2-90.9%&#x02020;</td><td align="center">81.0% (34/42)</td></tr></tbody></table><table-wrap-foot><p><bold><italic>Notes: </italic></bold>(1) ALA (aminolevulinic acid), APC (argon plasma coagulation), EMR (endoscopic mucosal resection), HpD (hematoporphyrin derivative), MPEC (multipolar electrocoagulation), mTHPC (meta-tetrahydroxyphenylchlorin), PDT (photodynamic therapy), RFA (radiofrequency ablation) (2) **- (pooled total not available), &#x02020; Ranges of the complete eradication rates post-endoscopic treatments for the included studies</p></table-wrap-foot></table-wrap><p>Results of 2 of the 3 RCTs of PDT (with ALA) versus APC in patients with BE demonstrated a significant difference in complete eradication, favouring APC over PDT[<xref ref-type="bibr" rid="B13">13</xref>,<xref ref-type="bibr" rid="B14">14</xref>]. Specifically, the complete eradication rates in the APC group were almost double that of the PDT group (Additional file <xref ref-type="supplementary-material" rid="S10">10</xref>). In the third RCT, complete eradication rates were not reported for both groups of patients[<xref ref-type="bibr" rid="B16">16</xref>].</p><p>Two RCTs reported on complete eradication of HGD[<xref ref-type="bibr" rid="B15">15</xref>,<xref ref-type="bibr" rid="B19">19</xref>]. In the RCT which compared PDT using porfimer sodium to APC, there was no statistically significant difference in complete eradication rate between treatment groups at 4 months follow-up[<xref ref-type="bibr" rid="B15">15</xref>]. In the RCT which compared RFA with sham procedure, there was a statistically significant difference in complete eradication rate between the group treated by RFA (81.0%) and the control group (19.0%) at 12 months follow-up[<xref ref-type="bibr" rid="B19">19</xref>].</p></sec></sec><sec><title>Discussion</title><p>Endoscopic therapies appear to be viable and effective treatment options for Barrett's esophagus with high grade dysplasia. All of the endoscopic therapies are safer (i.e., have fewer adverse events and lower mortality rates) than esophagectomy.</p><p>Some key questions regarding these treatments cannot yet be answered and further studies are needed to address these "gaps in the evidence". In particular, we need studies:</p><p>&#x02022; to confirm the long-term safety of these endoscopic treatments, and their effectiveness in preventing esophageal cancer</p><p>&#x02022; to identify the endoscopic treatments (or combinations of treatments) that produce the best outcomes</p><p>&#x02022; to determine whether or not continued drug therapy (e.g., with proton pump inhibitors) or surgery (e.g., fundoplication) to treat gastroesophageal reflux is beneficial after endoscopic treatment of dysplasia</p><p>&#x02022; to provide guidance on the optimal frequency of post-treatment endoscopic surveillance for patients with Barrett's esophagus</p><p>&#x02022; to measure patient preferences for, and quality of life after, the different endoscopic treatments.</p></sec><sec><title>Conclusions</title><p>Given the current limitations in the evidence (in terms of both quantity and quality of studies), it was not possible to conclusively determine the comparative effectiveness of the different endoscopic treatments. However, the evidence suggests that endoscopic treatments are safe and reasonably effective alternatives to esophagectomy for patients with Barrett's esophagus with high grade dysplasia. Endoscopic treatments have the additional advantages of being outpatient procedures with shorter recovery times. They also provide treatment options for patients who would not be considered for esophagectomy due to other health conditions.</p><p>Of the endoscopic therapies, photosensitivity is only an issue with photodynamic therapy (more so with porfimer sodium than with other photosensitizing agents). Preventing adverse events due to photosensitivity requires patient and caregiver compliance and education.</p><p>There appears to be little difference between the endoscopic technologies in terms of overall efficacy. Patient and physician preferences, and the local availability of the different technologies will likely guide decision making. A combination of different endoscopic treatments may provide the best outcomes. Given that relatively few patients need these treatments each year, offering them at specialized centres will concentrate clinical expertise and be the most cost-effective approach.</p></sec><sec><title>Competing interests</title><p>CW was the recipient of a one time clinical implementation grant from Axcan in 2007, and has given educational talks funded through unrestricted grants from Axcan. The remaining author(s) declare that they have no competing interests</p></sec><sec><title>Authors' contributions</title><p>DM and CW made substantial contributions to the conception and design of the study, to interpretation of the data, and have reviewed and revised the manuscript for important intellectual and clinical content. TS made a substantial contribution to the conception and design of the study, interpretation of data, and was involved in writing and critically reviewing drafts of the manuscript. HW was involved in the acquisition, analysis and interpretation of the data and making major revisions to draft manuscripts. DL was involved in the conception and design of the study, acquisition and analysis of data and drafting the manuscript. All authors have given approval for submission of this version.</p></sec><sec><title>Pre-publication history</title><p>The pre-publication history for this paper can be accessed here:</p><p><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-230X/10/111/prepub">http://www.biomedcentral.com/1471-230X/10/111/prepub</ext-link></p></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="S1"><caption><title>Additional file 1</title><p><bold>Studies of photodynamic therapy (PDT) for Barrett's esophagus with/without dysplasia</bold>. Details of study and patient characteristics, outcomes and study quality of the included studies of PDT for BE with/without dysplasia are presented in Additional file <xref ref-type="supplementary-material" rid="S1">1</xref>.</p></caption><media xlink:href="1471-230X-10-111-S1.DOC" mimetype="application" mime-subtype="msword"><caption><p>Click here for file</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="S2"><caption><title>Additional file 2</title><p><bold>Studies of argon plasma coagulation (APC) for Barrett's esophagus with/without dysplasia</bold>. Details of study and patient characteristics, outcomes and study quality of the included studies of APC for BE with/without dysplasia are presented in Additional file <xref ref-type="supplementary-material" rid="S2">2</xref>.</p></caption><media xlink:href="1471-230X-10-111-S2.DOC" mimetype="application" mime-subtype="msword"><caption><p>Click here for file</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="S3"><caption><title>Additional file 3</title><p><bold>Studies of cryoablation, combined endoscopic mucosal resection (EMR) and photodynamic therapy (PDT), and thermocoagulation for Barrett's esophagus with/without dysplasia</bold>. Details of study and patient characteristics, outcomes and study quality of the included studies of cryoablation, combined EMR and PDT, and thermocoagulation for BE with/without dysplasia are presented in Additional file <xref ref-type="supplementary-material" rid="S3">3</xref>.</p></caption><media xlink:href="1471-230X-10-111-S3.DOC" mimetype="application" mime-subtype="msword"><caption><p>Click here for file</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="S4"><caption><title>Additional file 4</title><p><bold>Studies of endoscopic mucosal resection (EMR) for Barrett's esophagus with/without dysplasia</bold>. Details of study and patient characteristics, outcomes and study quality of the included studies of EMR for BE with/without dysplasia are presented in Additional file <xref ref-type="supplementary-material" rid="S4">4</xref>.</p></caption><media xlink:href="1471-230X-10-111-S4.DOC" mimetype="application" mime-subtype="msword"><caption><p>Click here for file</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="S5"><caption><title>Additional file 5</title><p><bold>Studies of laser ablation for Barrett's esophagus with/without dysplasia</bold>. Details of study and patient characteristics, outcomes and study quality of the included studies of laser ablation for BE with/without dysplasia are presented in Additional file <xref ref-type="supplementary-material" rid="S5">5</xref>.</p></caption><media xlink:href="1471-230X-10-111-S5.DOC" mimetype="application" mime-subtype="msword"><caption><p>Click here for file</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="S6"><caption><title>Additional file 6</title><p><bold>Studies of multipolar electrocoaguation (MPEC) for Barrett's esophagus with/without dysplasia</bold>. Details of study and patient characteristics, outcomes and study quality of the included studies of MPEC for BE with/without dysplasia are presented in Additional file <xref ref-type="supplementary-material" rid="S6">6</xref>.</p></caption><media xlink:href="1471-230X-10-111-S6.DOC" mimetype="application" mime-subtype="msword"><caption><p>Click here for file</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="S7"><caption><title>Additional file 7</title><p><bold>Studies of radiofrequency ablation (RFA) for Barrett's esophagus with/without dysplasia</bold>. Details of study and patient characteristics, outcomes and study quality of the included studies of RFA for BE with/without dysplasia are presented in Additional file <xref ref-type="supplementary-material" rid="S7">7</xref>.</p></caption><media xlink:href="1471-230X-10-111-S7.DOC" mimetype="application" mime-subtype="msword"><caption><p>Click here for file</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="S8"><caption><title>Additional file 8</title><p><bold>Studies of esophagectomy for Barrett's esophagus with/without dysplasia</bold>. Details of study and patient characteristics, outcomes and study quality of the included studies of esophagectomy for BE with/without dysplasia are presented in Additional file <xref ref-type="supplementary-material" rid="S8">8</xref>.</p></caption><media xlink:href="1471-230X-10-111-S8.DOC" mimetype="application" mime-subtype="msword"><caption><p>Click here for file</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="S9"><caption><title>Additional file 9</title><p><bold>Studies of adverse events (endoscopic treatments)</bold>. Adverse events reported for individual studies of endoscopic alternatives are presented in Additional file <xref ref-type="supplementary-material" rid="S9">9</xref>.</p></caption><media xlink:href="1471-230X-10-111-S9.DOC" mimetype="application" mime-subtype="msword"><caption><p>Click here for file</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="S10"><caption><title>Additional file 10</title><p><bold>Studies of complete eradication of Barrett's esophagus (endoscopic treatments)</bold>. Values reported for the complete eradication of BE with endoscopic treatments are presented in Additional file <xref ref-type="supplementary-material" rid="S10">10</xref>.</p></caption><media xlink:href="1471-230X-10-111-S10.DOC" mimetype="application" mime-subtype="msword"><caption><p>Click here for file</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="S11"><caption><title>Additional file 11</title><p><bold>Studies of complete eradication of high grade dysplasia (endoscopic treatments)</bold>. Values reported for the complete eradication of HGD with endoscopic treatments are presented in Additional file <xref ref-type="supplementary-material" rid="S11">11</xref>.</p></caption><media xlink:href="1471-230X-10-111-S11.DOC" mimetype="application" mime-subtype="msword"><caption><p>Click here for file</p></caption></media></supplementary-material></sec></body><back><sec><title>Acknowledgements</title><p>This study was made possible through a financial contribution from Alberta Health and Wellness and under the auspices of the Alberta Health Technologies Decision Process initiative: the Alberta model for health technology assessment and policy analysis. The views expressed herein do not necessarily represent the official policy of Alberta Health and Wellness. The authors would like to thank Leigh-Ann Topfer for conducting the literature searches and editing the manuscript.</p></sec><ref-list><ref id="B1"><mixed-citation publication-type="journal"><name><surname>Tougas</surname><given-names>G</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Hwang</surname><given-names>P</given-names></name><name><surname>Liu</surname><given-names>MM</given-names></name><name><surname>Eggleston</surname><given-names>A</given-names></name><article-title>Prevalence and impact of upper gastrointestinal symptoms in the Canadian population: findings from the DIGEST study. Domestic/International Gastroenterology Surveillance Study</article-title><source>Am J Gastroenterol</source><year>1999</year><volume>94</volume><fpage>2845</fpage><lpage>2854</lpage><pub-id pub-id-type="doi">10.1111/j.1572-0241.1999.01427.x</pub-id><pub-id pub-id-type="pmid">10520832</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal"><name><surname>Ronkainen</surname><given-names>J</given-names></name><name><surname>Aro</surname><given-names>P</given-names></name><name><surname>Storskrubb</surname><given-names>T</given-names></name><name><surname>Johansson</surname><given-names>SE</given-names></name><name><surname>Lind</surname><given-names>T</given-names></name><name><surname>Bolling-Sternevald</surname><given-names>E</given-names></name><name><surname>Vieth</surname><given-names>M</given-names></name><name><surname>Stolte</surname><given-names>M</given-names></name><name><surname>Talley</surname><given-names>NJ</given-names></name><name><surname>Agreus</surname><given-names>L</given-names></name><article-title>Prevalence of Barrett's esophagus in the general population: an endoscopic study</article-title><source>Gastroenterology</source><year>2005</year><volume>129</volume><fpage>1825</fpage><lpage>1831</lpage><pub-id pub-id-type="doi">10.1053/j.gastro.2005.08.053</pub-id><pub-id pub-id-type="pmid">16344051</pub-id></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><name><surname>Esquivel</surname><given-names>RF</given-names></name><name><surname>Boolchang</surname><given-names>V</given-names></name><name><surname>Kumar</surname><given-names>N</given-names></name><name><surname>Camargo</surname><given-names>L</given-names></name><name><surname>Kim</surname><given-names>JL</given-names></name><name><surname>Fass</surname><given-names>R</given-names></name><name><surname>Sampliner</surname><given-names>RE</given-names></name><article-title>The prevalence of Barrett's esophagus in veteran patients with and without GERD symptoms undergoing outpatient colonoscopy [abstract]</article-title><source>Gastrointest Endosc</source><year>2008</year><volume>67</volume><fpage>AB172</fpage><pub-id pub-id-type="doi">10.1016/j.gie.2008.03.402</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal"><name><surname>Lao</surname><given-names>CD</given-names></name><name><surname>Simmons</surname><given-names>M</given-names></name><name><surname>Syngal</surname><given-names>S</given-names></name><name><surname>Bresalier</surname><given-names>RS</given-names></name><name><surname>Fortlage</surname><given-names>L</given-names></name><name><surname>Normolle</surname><given-names>D</given-names></name><name><surname>Griffith</surname><given-names>KA</given-names></name><name><surname>Appelman</surname><given-names>HD</given-names></name><name><surname>Brenner</surname><given-names>DE</given-names></name><article-title>Dysplasia in Barrett esophagus</article-title><source>Cancer</source><year>2004</year><volume>100</volume><fpage>1622</fpage><lpage>1627</lpage><pub-id pub-id-type="doi">10.1002/cncr.20149</pub-id><pub-id pub-id-type="pmid">15073848</pub-id></mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal"><name><surname>Hookey</surname><given-names>LC</given-names></name><article-title>Barrett's esophagus--who, how, how often and what to do with dysplasia?</article-title><source>Can J Gastroenterol</source><year>2006</year><volume>20</volume><fpage>463</fpage><lpage>466</lpage><pub-id pub-id-type="pmid">16858497</pub-id></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal"><name><surname>Yousef</surname><given-names>F</given-names></name><name><surname>Cardwell</surname><given-names>C</given-names></name><name><surname>Cantwell</surname><given-names>MM</given-names></name><name><surname>Galway</surname><given-names>K</given-names></name><name><surname>Johnston</surname><given-names>BT</given-names></name><name><surname>Murray</surname><given-names>L</given-names></name><article-title>The incidence of esophageal cancer and high-grade dysplasia in Barrett's esophagus: a systematic review and meta-analysis</article-title><source>Am J Epidemiol</source><year>2008</year><volume>168</volume><fpage>237</fpage><lpage>249</lpage><pub-id pub-id-type="doi">10.1093/aje/kwn121</pub-id><pub-id pub-id-type="pmid">18550563</pub-id></mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal"><name><surname>Willich</surname><given-names>SN</given-names></name><name><surname>Nocon</surname><given-names>M</given-names></name><name><surname>Kulig</surname><given-names>M</given-names></name><name><surname>Jaspersen</surname><given-names>D</given-names></name><name><surname>Labenz</surname><given-names>J</given-names></name><name><surname>Meyer-Sabellek</surname><given-names>W</given-names></name><name><surname>Stolte</surname><given-names>M</given-names></name><name><surname>Lind</surname><given-names>T</given-names></name><name><surname>Malfertheiner</surname><given-names>P</given-names></name><article-title>Cost-of-disease analysis in patients with gastro-oesophageal reflux disease and Barrett's mucosa</article-title><source>Aliment Pharmacol Ther</source><year>2006</year><volume>23</volume><fpage>371</fpage><lpage>376</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2036.2006.02763.x</pub-id><pub-id pub-id-type="pmid">16422996</pub-id></mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal"><name><surname>Amonkar</surname><given-names>MM</given-names></name><name><surname>Kalsekar</surname><given-names>ID</given-names></name><name><surname>Boyer</surname><given-names>JG</given-names></name><article-title>The economic burden of Barrett's esophagus in a Medicaid population</article-title><source>Ann Pharmacother</source><year>2002</year><volume>36</volume><fpage>605</fpage><lpage>611</lpage><pub-id pub-id-type="doi">10.1345/aph.1A309</pub-id><pub-id pub-id-type="pmid">11918506</pub-id></mixed-citation></ref><ref id="B9"><mixed-citation publication-type="other"><name><surname>Green</surname><given-names>S</given-names></name><name><surname>Tawil</surname><given-names>A</given-names></name><name><surname>Barr</surname><given-names>H</given-names></name><name><surname>Bennett</surname><given-names>C</given-names></name><name><surname>Bhandari</surname><given-names>P</given-names></name><name><surname>DeCaestecker</surname><given-names>J</given-names></name><name><surname>Ragunath</surname><given-names>K</given-names></name><name><surname>Singh</surname><given-names>R</given-names></name><name><surname>Jankowski</surname><given-names>J</given-names></name><article-title>Surgery versus radical endotherapies for early cancer and high grade dysplasia in Barrett's oesophagus</article-title><source>Cochrane Library</source><year>2009</year></mixed-citation></ref><ref id="B10"><mixed-citation publication-type="journal"><name><surname>Reynolds</surname><given-names>JV</given-names></name><name><surname>McLaughlin</surname><given-names>R</given-names></name><name><surname>Moore</surname><given-names>J</given-names></name><name><surname>Rowley</surname><given-names>S</given-names></name><name><surname>Ravi</surname><given-names>N</given-names></name><name><surname>Byrne</surname><given-names>PJ</given-names></name><article-title>Prospective evaluation of quality of life in patients with localized oesophageal cancer treated by multimodality therapy or surgery alone</article-title><source>Br J Surg</source><year>2006</year><volume>93</volume><fpage>1084</fpage><lpage>1090</lpage><pub-id pub-id-type="doi">10.1002/bjs.5373</pub-id><pub-id pub-id-type="pmid">16779881</pub-id></mixed-citation></ref><ref id="B11"><mixed-citation publication-type="journal"><name><surname>Qureshi</surname><given-names>I</given-names></name><name><surname>Nason</surname><given-names>KS</given-names></name><name><surname>Luketich</surname><given-names>JD</given-names></name><article-title>Is minimally invasive esophagectomy indicated for cancer?</article-title><source>Expert Rev Anticancer Ther</source><year>2008</year><volume>8</volume><fpage>1449</fpage><lpage>1460</lpage><pub-id pub-id-type="doi">10.1586/14737140.8.9.1449</pub-id><pub-id pub-id-type="pmid">18759696</pub-id></mixed-citation></ref><ref id="B12"><mixed-citation publication-type="book"><name><surname>Phillips</surname><given-names>B</given-names></name><name><surname>Ball</surname><given-names>C</given-names></name><name><surname>Sackett</surname><given-names>D</given-names></name><name><surname>Badenoch</surname><given-names>D</given-names></name><name><surname>Straus</surname><given-names>S</given-names></name><name><surname>Haynes</surname><given-names>B</given-names></name><name><surname>Dawes</surname><given-names>M</given-names></name><source>Oxford Centre for Evidence-based Medicine levels of evidence and grades of recommendation</source><year>2001</year><publisher-name>Oxford (UK): Oxford Centre for Evidence-based Medicine</publisher-name></mixed-citation></ref><ref id="B13"><mixed-citation publication-type="journal"><name><surname>Hage</surname><given-names>M</given-names></name><name><surname>Siersema</surname><given-names>PD</given-names></name><name><surname>van</surname><given-names>DH</given-names></name><name><surname>Steyerberg</surname><given-names>EW</given-names></name><name><surname>Haringsma</surname><given-names>J</given-names></name><name><surname>van d</surname><given-names>V</given-names></name><name><surname>Grool</surname><given-names>TE</given-names></name><name><surname>van Veen</surname><given-names>RL</given-names></name><name><surname>Sterenborg</surname><given-names>HJ</given-names></name><name><surname>Kuipers</surname><given-names>EJ</given-names></name><article-title>5-aminolevulinic acid photodynamic therapy versus argon plasma coagulation for ablation of Barrett's oesophagus: a randomised trial</article-title><source>Gut</source><year>2004</year><volume>53</volume><fpage>785</fpage><lpage>790</lpage><pub-id pub-id-type="doi">10.1136/gut.2003.028860</pub-id><pub-id pub-id-type="pmid">15138203</pub-id></mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal"><name><surname>Kelty</surname><given-names>CJ</given-names></name><name><surname>Ackroyd</surname><given-names>R</given-names></name><name><surname>Brown</surname><given-names>NJ</given-names></name><name><surname>Stephenson</surname><given-names>TJ</given-names></name><name><surname>Stoddard</surname><given-names>CJ</given-names></name><name><surname>Reed</surname><given-names>MW</given-names></name><article-title>Endoscopic ablation of Barrett's oesophagus: a randomized-controlled trial of photodynamic therapy vs. argon plasma coagulation</article-title><source>Aliment Pharmacol Ther</source><year>2004</year><volume>20</volume><fpage>1289</fpage><lpage>1296</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2036.2004.02277.x</pub-id><pub-id pub-id-type="pmid">15606390</pub-id></mixed-citation></ref><ref id="B15"><mixed-citation publication-type="journal"><name><surname>Ragunath</surname><given-names>K</given-names></name><name><surname>Krasner</surname><given-names>N</given-names></name><name><surname>Raman</surname><given-names>VS</given-names></name><name><surname>Haqqani</surname><given-names>MT</given-names></name><name><surname>Phillips</surname><given-names>CJ</given-names></name><name><surname>Cheung</surname><given-names>I</given-names></name><article-title>Endoscopic ablation of dysplastic Barrett's oesophagus comparing argon plasma coagulation and photodynamic therapy: a randomized prospective trial assessing efficacy and cost-effectiveness</article-title><source>Scand J Gastroenterol</source><year>2005</year><volume>40</volume><fpage>750</fpage><lpage>758</lpage><pub-id pub-id-type="doi">10.1080/00365520510015737</pub-id><pub-id pub-id-type="pmid">16118910</pub-id></mixed-citation></ref><ref id="B16"><mixed-citation publication-type="journal"><name><surname>Zoepf</surname><given-names>T</given-names></name><name><surname>Alsenbesy</surname><given-names>M</given-names></name><name><surname>Jakobs</surname><given-names>R</given-names></name><name><surname>Apel</surname><given-names>D</given-names></name><name><surname>Rosenbaum</surname><given-names>A</given-names></name><name><surname>Riemann</surname><given-names>JF</given-names></name><article-title>Photodynamic therapy (PDT) versus argon plasma, coagulation (APC) for ablative therapy of Barrett's esophagus [abstract]</article-title><source>Gastrointest Endosc</source><year>2003</year><volume>57</volume><fpage>AB139</fpage></mixed-citation></ref><ref id="B17"><mixed-citation publication-type="journal"><name><surname>Dulai</surname><given-names>GS</given-names></name><name><surname>Jensen</surname><given-names>DM</given-names></name><name><surname>Cortina</surname><given-names>G</given-names></name><name><surname>Fontana</surname><given-names>L</given-names></name><name><surname>Ippoliti</surname><given-names>A</given-names></name><article-title>Randomized trial of argon plasma coagulation vs. multipolar electrocoagulation for ablation of Barrett's esophagus</article-title><source>Gastrointest Endosc</source><year>2005</year><volume>61</volume><fpage>232</fpage><lpage>240</lpage><pub-id pub-id-type="doi">10.1016/S0016-5107(04)02576-3</pub-id><pub-id pub-id-type="pmid">15729231</pub-id></mixed-citation></ref><ref id="B18"><mixed-citation publication-type="journal"><name><surname>Sharma</surname><given-names>P</given-names></name><name><surname>Wani</surname><given-names>S</given-names></name><name><surname>Weston</surname><given-names>AP</given-names></name><name><surname>Bansal</surname><given-names>A</given-names></name><name><surname>Hall</surname><given-names>M</given-names></name><name><surname>Mathur</surname><given-names>S</given-names></name><name><surname>Prasad</surname><given-names>A</given-names></name><name><surname>Sampliner</surname><given-names>RE</given-names></name><article-title>A randomised controlled trial of ablation of Barrett's oesophagus with multipolar electrocoagulation versus argon plasma coagulation in combination with acid suppression: long term results</article-title><source>Gut</source><year>2006</year><volume>55</volume><fpage>1233</fpage><lpage>1239</lpage><pub-id pub-id-type="doi">10.1136/gut.2005.086777</pub-id><pub-id pub-id-type="pmid">16905695</pub-id></mixed-citation></ref><ref id="B19"><mixed-citation publication-type="journal"><name><surname>Shaheen</surname><given-names>NJ</given-names></name><name><surname>Sharma</surname><given-names>P</given-names></name><name><surname>Overholt</surname><given-names>BF</given-names></name><name><surname>Wolfsen</surname><given-names>HC</given-names></name><name><surname>Sampliner</surname><given-names>RE</given-names></name><name><surname>Wang</surname><given-names>KK</given-names></name><name><surname>Galanko</surname><given-names>JA</given-names></name><name><surname>Bronner</surname><given-names>MP</given-names></name><name><surname>Goldblum</surname><given-names>JR</given-names></name><name><surname>Bennett</surname><given-names>AE</given-names></name><etal/><article-title>Radiofrequency ablation in Barrett's esophagus with dysplasia</article-title><source>N Eng J Med</source><year>2009</year><volume>360</volume><fpage>2277</fpage><lpage>2288</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa0808145</pub-id></mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal"><name><surname>Reed</surname><given-names>MF</given-names></name><name><surname>Tolis</surname><given-names>G</given-names><suffix>Jr</suffix></name><name><surname>Edil</surname><given-names>BH</given-names></name><name><surname>Allan</surname><given-names>JS</given-names></name><name><surname>Donahue</surname><given-names>DM</given-names></name><name><surname>Gaissert</surname><given-names>HA</given-names></name><name><surname>Moncure</surname><given-names>AC</given-names></name><name><surname>Wain</surname><given-names>JC</given-names></name><name><surname>Wright</surname><given-names>CD</given-names></name><name><surname>Mathisen</surname><given-names>DJ</given-names></name><article-title>Surgical treatment of esophageal high-grade dysplasia</article-title><source>Ann Thorac Surg</source><year>2005</year><volume>79</volume><fpage>1110</fpage><lpage>1115</lpage><pub-id pub-id-type="doi">10.1016/j.athoracsur.2004.09.006</pub-id><pub-id pub-id-type="pmid">15797034</pub-id></mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal"><name><surname>Prasad</surname><given-names>GA</given-names></name><name><surname>Wang</surname><given-names>KK</given-names></name><name><surname>Buttar</surname><given-names>NS</given-names></name><name><surname>Wongkeesong</surname><given-names>LM</given-names></name><name><surname>Krishnadath</surname><given-names>KK</given-names></name><name><surname>Nichols</surname><given-names>FC</given-names><suffix>III</suffix></name><name><surname>Lutzke</surname><given-names>LS</given-names></name><name><surname>Borkenhagen</surname><given-names>LS</given-names></name><article-title>Long-term survival following endoscopic and surgical treatment of high-grade dysplasia in Barrett's esophagus</article-title><source>Gastroenterology</source><year>2007</year><volume>132</volume><fpage>1226</fpage><lpage>1233</lpage><pub-id pub-id-type="doi">10.1053/j.gastro.2007.02.017</pub-id><pub-id pub-id-type="pmid">17408660</pub-id></mixed-citation></ref><ref id="B22"><mixed-citation publication-type="journal"><name><surname>Mackenzie</surname><given-names>G</given-names></name><name><surname>Clark</surname><given-names>BR</given-names></name><name><surname>Selvasekar</surname><given-names>C</given-names></name><name><surname>Jamieson</surname><given-names>N</given-names></name><name><surname>Novelli</surname><given-names>M</given-names></name><name><surname>Thorpe</surname><given-names>S</given-names></name><name><surname>Mosse</surname><given-names>C</given-names></name><name><surname>Bown</surname><given-names>S</given-names></name><name><surname>Lovat</surname><given-names>L</given-names></name><article-title>Photodynamic therapy with 5 aminolevulinic acid for high grade dysplasia in Barrett's esophagus: Longterm follow up of 51 patients [abstract]</article-title><source>Gastroenterology</source><year>2005</year><volume>128</volume><fpage>A238</fpage><pub-id pub-id-type="doi">10.1053/j.gastro.2004.11.026</pub-id></mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal"><name><surname>Manner</surname><given-names>H</given-names></name><name><surname>May</surname><given-names>A</given-names></name><name><surname>Miehlke</surname><given-names>S</given-names></name><name><surname>Dertinger</surname><given-names>S</given-names></name><name><surname>Wigginghaus</surname><given-names>B</given-names></name><name><surname>Schimming</surname><given-names>W</given-names></name><name><surname>Kramer</surname><given-names>W</given-names></name><name><surname>Niemann</surname><given-names>G</given-names></name><name><surname>Stolte</surname><given-names>M</given-names></name><name><surname>Ell</surname><given-names>C</given-names></name><article-title>Ablation of nonneoplastic Barrett's mucosa using argon plasma coagulation with concomitant esomeprazole therapy (APBANEX): a prospective multicenter evaluation</article-title><source>Am J Gastroenterol</source><year>2006</year><volume>101</volume><fpage>1762</fpage><lpage>1769</lpage><pub-id pub-id-type="doi">10.1111/j.1572-0241.2006.00709.x</pub-id><pub-id pub-id-type="pmid">16817835</pub-id></mixed-citation></ref><ref id="B24"><mixed-citation publication-type="journal"><name><surname>Fisher</surname><given-names>RS</given-names></name><name><surname>Bromer</surname><given-names>MQ</given-names></name><name><surname>Thomas</surname><given-names>RM</given-names></name><name><surname>Cohen</surname><given-names>S</given-names></name><name><surname>Krevsky</surname><given-names>B</given-names></name><name><surname>Horwitz</surname><given-names>B</given-names></name><name><surname>Glazier</surname><given-names>KD</given-names></name><name><surname>Das</surname><given-names>K</given-names></name><name><surname>Das</surname><given-names>KA</given-names></name><article-title>Predictors of recurrent specialized intestinal metaplasia after complete laser ablation</article-title><source>Am J Gastroenterol</source><year>2003</year><volume>98</volume><fpage>1945</fpage><lpage>1951</lpage><pub-id pub-id-type="doi">10.1111/j.1572-0241.2003.07628.x</pub-id><pub-id pub-id-type="pmid">14499770</pub-id></mixed-citation></ref><ref id="B25"><mixed-citation publication-type="journal"><name><surname>Behrens</surname><given-names>A</given-names></name><name><surname>May</surname><given-names>A</given-names></name><name><surname>Gossner</surname><given-names>L</given-names></name><name><surname>Gunter</surname><given-names>E</given-names></name><name><surname>Pech</surname><given-names>O</given-names></name><name><surname>Vieth</surname><given-names>M</given-names></name><name><surname>Stolte</surname><given-names>M</given-names></name><name><surname>Seitz</surname><given-names>G</given-names></name><name><surname>Ell</surname><given-names>C</given-names></name><article-title>Curative treatment for high-grade intraepithelial neoplasia in Barrett's esophagus</article-title><source>Endoscopy</source><year>2005</year><volume>37</volume><fpage>999</fpage><lpage>1005</lpage><pub-id pub-id-type="doi">10.1055/s-2005-870352</pub-id><pub-id pub-id-type="pmid">16189774</pub-id></mixed-citation></ref><ref id="B26"><mixed-citation publication-type="journal"><name><surname>Ortner</surname><given-names>MA</given-names></name><name><surname>Zumbusch</surname><given-names>K</given-names></name><name><surname>Liebetruth</surname><given-names>J</given-names></name><name><surname>Ebert</surname><given-names>B</given-names></name><name><surname>Fleige</surname><given-names>B</given-names></name><name><surname>Dietel</surname><given-names>M</given-names></name><name><surname>Lochs</surname><given-names>H</given-names></name><article-title>Is topical delta-aminolevulinic acid adequate for photodynamic therapy in Barrett's esophagus? A pilot study</article-title><source>Endoscopy</source><year>2002</year><volume>34</volume><fpage>611</fpage><lpage>616</lpage><pub-id pub-id-type="doi">10.1055/s-2002-33247</pub-id><pub-id pub-id-type="pmid">12173080</pub-id></mixed-citation></ref><ref id="B27"><mixed-citation publication-type="journal"><name><surname>Ortner</surname><given-names>M</given-names></name><name><surname>Zumbusch</surname><given-names>K</given-names></name><name><surname>Liebetruth</surname><given-names>J</given-names></name><name><surname>Ernst</surname><given-names>H</given-names></name><name><surname>Weber</surname><given-names>J</given-names></name><name><surname>Wirth</surname><given-names>J</given-names></name><name><surname>Wedel</surname><given-names>S</given-names></name><name><surname>Lochs</surname><given-names>H</given-names></name><article-title>Photodynamic therapy of Barrett's esophagus after local administration of 5-aminolaevulinic acid [abstract]</article-title><source>Gastroenterology</source><year>1997</year><volume>112</volume><fpage>A633</fpage></mixed-citation></ref><ref id="B28"><mixed-citation publication-type="journal"><name><surname>Ackroyd</surname><given-names>R</given-names></name><name><surname>Kelty</surname><given-names>CJ</given-names></name><name><surname>Brown</surname><given-names>NJ</given-names></name><name><surname>Stephenson</surname><given-names>TJ</given-names></name><name><surname>Stoddard</surname><given-names>CJ</given-names></name><name><surname>Reed</surname><given-names>MW</given-names></name><article-title>Eradication of dysplastic Barrett's oesophagus using photodynamic therapy: long-term follow-up</article-title><source>Endoscopy</source><year>2003</year><volume>35</volume><fpage>496</fpage><lpage>501</lpage><pub-id pub-id-type="doi">10.1055/s-2003-39676</pub-id><pub-id pub-id-type="pmid">12783347</pub-id></mixed-citation></ref><ref id="B29"><mixed-citation publication-type="journal"><name><surname>Ackroyd</surname><given-names>R</given-names></name><name><surname>Davis</surname><given-names>MF</given-names></name><name><surname>Brown</surname><given-names>NJ</given-names></name><name><surname>Stephenson</surname><given-names>TJ</given-names></name><name><surname>Stoddard</surname><given-names>CJ</given-names></name><name><surname>Reed</surname><given-names>MWR</given-names></name><article-title>Photodynamic therapy (PDT): a new treatment for Barrett's oesophagus [abstract]</article-title><source>Lasers Med Sci</source><year>1997</year><volume>12</volume><fpage>292</fpage></mixed-citation></ref><ref id="B30"><mixed-citation publication-type="journal"><name><surname>Ackroyd</surname><given-names>R</given-names></name><name><surname>Brown</surname><given-names>NJ</given-names></name><name><surname>Davis</surname><given-names>MF</given-names></name><name><surname>Stephenson</surname><given-names>TJ</given-names></name><name><surname>Stoddard</surname><given-names>CJ</given-names></name><name><surname>Reed</surname><given-names>MWR</given-names></name><article-title>Aminolaevulinic acid-induced photodynamic therapy in the treatment of dysplastic Barrett's oesophagus and adenocarcinoma</article-title><source>Lasers Med Sci</source><year>1999</year><volume>14</volume><fpage>278</fpage><lpage>285</lpage><pub-id pub-id-type="doi">10.1007/s101030050095</pub-id></mixed-citation></ref><ref id="B31"><mixed-citation publication-type="journal"><name><surname>Mackenzie</surname><given-names>G</given-names></name><name><surname>Selvasekar</surname><given-names>C</given-names></name><name><surname>Clark</surname><given-names>BR</given-names></name><name><surname>Novelli</surname><given-names>M</given-names></name><name><surname>Thorpe</surname><given-names>S</given-names></name><name><surname>Mosse</surname><given-names>C</given-names></name><name><surname>Bown</surname><given-names>S</given-names></name><name><surname>Lovat</surname><given-names>L</given-names></name><article-title>Randomised controlled trial of photodynamic therapy using low dose 5 aminolevulinic acid activated by red or green light for high grade dysplasia in Barrett's esophagus [abstract]</article-title><source>Gastroenterology</source><year>2005</year><volume>128</volume><fpage>A238</fpage><pub-id pub-id-type="doi">10.1053/j.gastro.2004.11.026</pub-id></mixed-citation></ref><ref id="B32"><mixed-citation publication-type="journal"><name><surname>Peters</surname><given-names>F</given-names></name><name><surname>Kara</surname><given-names>M</given-names></name><name><surname>Rosmolen</surname><given-names>W</given-names></name><name><surname>Aalders</surname><given-names>M</given-names></name><name><surname>ten</surname><given-names>KF</given-names></name><name><surname>Krishnadath</surname><given-names>K</given-names></name><name><surname>van</surname><given-names>LJ</given-names></name><name><surname>Fockens</surname><given-names>P</given-names></name><name><surname>Bergman</surname><given-names>J</given-names></name><article-title>Poor results of 5-aminolevulinic acid-photodynamic therapy for residual high-grade dysplasia and early cancer in barrett esophagus after endoscopic resection</article-title><source>Endoscopy</source><year>2005</year><volume>37</volume><fpage>418</fpage><lpage>424</lpage><pub-id pub-id-type="doi">10.1055/s-2005-861198</pub-id><pub-id pub-id-type="pmid">15844019</pub-id></mixed-citation></ref><ref id="B33"><mixed-citation publication-type="journal"><name><surname>van Hillegersberg</surname><given-names>R</given-names></name><name><surname>Haringsma</surname><given-names>J</given-names></name><name><surname>Ten Kate</surname><given-names>FJ</given-names></name><name><surname>Tytgat</surname><given-names>GN</given-names></name><name><surname>van Lanschot</surname><given-names>JJ</given-names></name><article-title>Invasive carcinoma after endoscopic ablative therapy for high-grade dysplasia in Barrett's oesophagus</article-title><source>Dig Surg</source><year>2003</year><volume>20</volume><fpage>440</fpage><lpage>444</lpage><pub-id pub-id-type="doi">10.1159/000072713</pub-id><pub-id pub-id-type="pmid">12900536</pub-id></mixed-citation></ref><ref id="B34"><mixed-citation publication-type="journal"><name><surname>Barr</surname><given-names>H</given-names></name><name><surname>Shepherd</surname><given-names>NA</given-names></name><name><surname>Dix</surname><given-names>A</given-names></name><name><surname>Roberts</surname><given-names>DJ</given-names></name><name><surname>Tan</surname><given-names>WC</given-names></name><name><surname>Krasner</surname><given-names>N</given-names></name><article-title>Eradication of high-grade dysplasia in columnar-lined (Barrett's) oesophagus by photodynamic therapy with endogenously generated protoporphyrin IX</article-title><source>Lancet</source><year>1996</year><volume>348</volume><fpage>584</fpage><lpage>585</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(96)03054-1</pub-id><pub-id pub-id-type="pmid">8774572</pub-id></mixed-citation></ref><ref id="B35"><mixed-citation publication-type="journal"><name><surname>Gossner</surname><given-names>L</given-names></name><name><surname>Stolte</surname><given-names>M</given-names></name><name><surname>Sroka</surname><given-names>R</given-names></name><name><surname>Rick</surname><given-names>K</given-names></name><name><surname>May</surname><given-names>A</given-names></name><name><surname>Hahn</surname><given-names>EG</given-names></name><name><surname>Ell</surname><given-names>C</given-names></name><article-title>Photodynamic ablation of high-grade dysplasia and early cancer in Barrett's esophagus by means of 5-aminolevulinic acid</article-title><source>Gastroenterology</source><year>1998</year><volume>114</volume><fpage>448</fpage><lpage>455</lpage><pub-id pub-id-type="doi">10.1016/S0016-5085(98)70527-X</pub-id><pub-id pub-id-type="pmid">9496934</pub-id></mixed-citation></ref><ref id="B36"><mixed-citation publication-type="journal"><name><surname>Gossner</surname><given-names>L</given-names></name><name><surname>May</surname><given-names>A</given-names></name><name><surname>Sroka</surname><given-names>R</given-names></name><name><surname>Ell</surname><given-names>C</given-names></name><article-title>A new long-range through-the-scope balloon applicator for photodynamic therapy in the esophagus and cardia</article-title><source>Endoscopy</source><year>1999</year><volume>31</volume><fpage>370</fpage><lpage>376</lpage><pub-id pub-id-type="doi">10.1055/s-1999-31</pub-id><pub-id pub-id-type="pmid">10433046</pub-id></mixed-citation></ref><ref id="B37"><mixed-citation publication-type="journal"><name><surname>Kashtan</surname><given-names>H</given-names></name><name><surname>Umansky</surname><given-names>M</given-names></name><name><surname>Birkenfeld</surname><given-names>S</given-names></name><name><surname>Scherubl</surname><given-names>H</given-names></name><name><surname>Haddad</surname><given-names>R</given-names></name><name><surname>Greenberg</surname><given-names>R</given-names></name><name><surname>Konikoff</surname><given-names>F</given-names></name><article-title>Photodynamic therapy of Barrett's esophagus with dysplasia using systemic aminolevulinic acid and a non-laser light source. A phase I/II study</article-title><source>Gastrointestinal Oncology</source><year>2002</year><volume>4</volume><fpage>153</fpage><lpage>157</lpage><pub-id pub-id-type="doi">10.1080/1475956021000017020</pub-id></mixed-citation></ref><ref id="B38"><mixed-citation publication-type="journal"><name><surname>Mackenzie</surname><given-names>GD</given-names></name><name><surname>Dunn</surname><given-names>JM</given-names></name><name><surname>Novelli</surname><given-names>MR</given-names></name><name><surname>Mosse</surname><given-names>S</given-names></name><name><surname>Thorpe</surname><given-names>SM</given-names></name><name><surname>Bown</surname><given-names>SG</given-names></name><name><surname>Lovat</surname><given-names>LB</given-names></name><article-title>Preliminary results of a randomised controlled trial into the safety and efficacy of ALA versus photofrin photodynamic therapy for high grade dysplasia in Barrett's oesophagus [abstract]</article-title><source>Gut</source><year>2008</year><volume>57</volume><fpage>A14</fpage></mixed-citation></ref><ref id="B39"><mixed-citation publication-type="journal"><name><surname>Macrae</surname><given-names>FA</given-names></name><name><surname>Rajesekaram</surname><given-names>R</given-names></name><name><surname>Thomas</surname><given-names>R</given-names></name><name><surname>Bhathal</surname><given-names>PS</given-names></name><article-title>Photodynamic therapy in high grade dysplasia in Barrett's oesophagus using 5 amino-laevulinic acid sensitization [abstract]</article-title><source>Gastrointest Endosc</source><year>2004</year><volume>59</volume><fpage>P252</fpage><pub-id pub-id-type="doi">10.1016/S0016-5107(04)01128-9</pub-id></mixed-citation></ref><ref id="B40"><mixed-citation publication-type="journal"><name><surname>Mellidez</surname><given-names>JC</given-names></name><name><surname>Mackenzie</surname><given-names>G</given-names></name><name><surname>Selvasekar</surname><given-names>C</given-names></name><name><surname>Novelli</surname><given-names>M</given-names></name><name><surname>Thorpe</surname><given-names>S</given-names></name><name><surname>Mosse</surname><given-names>C</given-names></name><name><surname>Bown</surname><given-names>S</given-names></name><name><surname>Lovat</surname><given-names>L</given-names></name><article-title>Reversal of Barrett's esophagus following photodynamic therapy using high dose 5 aminolevulinic acid activated by red or green laser light [abstract]</article-title><source>Gastroenterology</source><year>2005</year><volume>128</volume><fpage>A239</fpage><pub-id pub-id-type="doi">10.1053/j.gastro.2004.11.027</pub-id></mixed-citation></ref><ref id="B41"><mixed-citation publication-type="journal"><name><surname>Laukka</surname><given-names>MA</given-names></name><name><surname>Wang</surname><given-names>KK</given-names></name><article-title>Initial results using low-dose photodynamic therapy in the treatment of Barrett's esophagus</article-title><source>Gastrointest Endosc</source><year>1995</year><volume>42</volume><fpage>59</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1016/S0016-5107(95)70245-8</pub-id><pub-id pub-id-type="pmid">7557179</pub-id></mixed-citation></ref><ref id="B42"><mixed-citation publication-type="journal"><name><surname>Wang</surname><given-names>KK</given-names></name><name><surname>Wongkeesong</surname><given-names>LM</given-names></name><name><surname>Nourbakhsh</surname><given-names>A</given-names></name><name><surname>Laukka</surname><given-names>M</given-names></name><name><surname>Gutta</surname><given-names>K</given-names></name><name><surname>Geller</surname><given-names>A</given-names></name><name><surname>Balm</surname><given-names>R</given-names></name><article-title>Controlled trial of low dose photodynamic therapy for Barrett's esophagus [abstract]</article-title><source>Gastroenterology</source><year>1997</year><volume>112</volume><fpage>A676</fpage></mixed-citation></ref><ref id="B43"><mixed-citation publication-type="journal"><name><surname>Wang</surname><given-names>KK</given-names></name><name><surname>Nijhawan</surname><given-names>P</given-names></name><name><surname>Nourbakhsh</surname><given-names>A</given-names></name><name><surname>Lutzke</surname><given-names>L</given-names></name><name><surname>WongKeeSong</surname><given-names>M</given-names></name><name><surname>Anderson</surname><given-names>M</given-names></name><article-title>Does residual Barrett's esophagus progress after photodynamic therapy? [abstract]</article-title><source>Gastroenterology</source><year>1999</year><volume>116</volume><fpage>A348</fpage></mixed-citation></ref><ref id="B44"><mixed-citation publication-type="journal"><name><surname>Javaid</surname><given-names>B</given-names></name><name><surname>Watt</surname><given-names>P</given-names></name><name><surname>Krasner</surname><given-names>N</given-names></name><article-title>Photodynamic therapy (PDT) for oesophageal dysplasia and early carcinoma with mTHPC (m-tetrahydroxyphenyl chlorin): a preliminary study</article-title><source>Lasers Med Sci</source><year>2002</year><volume>17</volume><fpage>51</fpage><lpage>56</lpage><pub-id pub-id-type="doi">10.1007/s10103-002-8266-5</pub-id><pub-id pub-id-type="pmid">11845368</pub-id></mixed-citation></ref><ref id="B45"><mixed-citation publication-type="journal"><name><surname>Lovat</surname><given-names>LB</given-names></name><name><surname>Jamieson</surname><given-names>NF</given-names></name><name><surname>Novelli</surname><given-names>MR</given-names></name><name><surname>Mosse</surname><given-names>CA</given-names></name><name><surname>Selvasekar</surname><given-names>C</given-names></name><name><surname>Mackenzie</surname><given-names>GD</given-names></name><name><surname>Thorpe</surname><given-names>SM</given-names></name><name><surname>Bown</surname><given-names>SG</given-names></name><article-title>Photodynamic therapy with m-tetrahydroxyphenyl chlorin for high-grade dysplasia and early cancer in Barrett's columnar lined esophagus</article-title><source>Gastrointest Endosc</source><year>2005</year><volume>62</volume><fpage>617</fpage><lpage>623</lpage><pub-id pub-id-type="doi">10.1016/j.gie.2005.04.043</pub-id><pub-id pub-id-type="pmid">16185985</pub-id></mixed-citation></ref><ref id="B46"><mixed-citation publication-type="journal"><name><surname>Attila</surname><given-names>T</given-names></name><name><surname>Kortan</surname><given-names>P</given-names></name><name><surname>Kandel</surname><given-names>GT</given-names></name><name><surname>Marcon</surname><given-names>N</given-names></name><article-title>Photodynamic therapy (PDT) for Barrett's esophagus with high grade dysplasia (BE-HGD) [abstract]</article-title><source>Gastrointest Endosc</source><year>2005</year><volume>61</volume><fpage>AB127</fpage><pub-id pub-id-type="doi">10.1016/S0016-5107(05)00760-1</pub-id></mixed-citation></ref><ref id="B47"><mixed-citation publication-type="journal"><name><surname>Bronner</surname><given-names>M</given-names></name><name><surname>Taylor</surname><given-names>S</given-names></name><name><surname>Overholt</surname><given-names>B</given-names></name><name><surname>Wang</surname><given-names>K</given-names></name><name><surname>Burdick</surname><given-names>S</given-names></name><name><surname>Lightdale</surname><given-names>C</given-names></name><name><surname>Kimmey</surname><given-names>M</given-names></name><name><surname>Nava</surname><given-names>H</given-names></name><name><surname>Sivak</surname><given-names>M</given-names></name><name><surname>Nishioka</surname><given-names>N</given-names></name><etal/><article-title>Squamous overgrowth in a 5-year randomized phase III trial of photodynamic therapy using porfirmer sodium in ablation of high-grade dysplasia in Barrett's esophagus [abstract]</article-title><source>Gastroenterology</source><year>2006</year><volume>130</volume><fpage>A121</fpage></mixed-citation></ref><ref id="B48"><mixed-citation publication-type="journal"><name><surname>Keeley</surname><given-names>SB</given-names></name><name><surname>Pennathur</surname><given-names>A</given-names></name><name><surname>Gooding</surname><given-names>W</given-names></name><name><surname>Landreneau</surname><given-names>RJ</given-names></name><name><surname>Christie</surname><given-names>NA</given-names></name><name><surname>Luketich</surname><given-names>J</given-names></name><article-title>Photodynamic therapy with curative intent for Barrett's esophagus with high grade dysplasia and superficial esophageal cancer</article-title><source>Ann Surg Oncol</source><year>2007</year><volume>14</volume><fpage>2406</fpage><lpage>2410</lpage><pub-id pub-id-type="doi">10.1245/s10434-007-9392-x</pub-id><pub-id pub-id-type="pmid">17534685</pub-id></mixed-citation></ref><ref id="B49"><mixed-citation publication-type="journal"><name><surname>Overholt</surname><given-names>BF</given-names></name><name><surname>Wang</surname><given-names>KK</given-names></name><name><surname>Burdick</surname><given-names>JS</given-names></name><name><surname>Lightdale</surname><given-names>CJ</given-names></name><name><surname>Kimmey</surname><given-names>M</given-names></name><name><surname>Nava</surname><given-names>HR</given-names></name><name><surname>Sivak</surname><given-names>MV</given-names><suffix>Jr</suffix></name><name><surname>Nishioka</surname><given-names>N</given-names></name><name><surname>Barr</surname><given-names>H</given-names></name><name><surname>Marcon</surname><given-names>N</given-names></name><etal/><article-title>Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett's high-grade dysplasia</article-title><source>Gastrointest Endosc</source><year>2007</year><volume>66</volume><fpage>460</fpage><lpage>468</lpage><pub-id pub-id-type="doi">10.1016/j.gie.2006.12.037</pub-id><pub-id pub-id-type="pmid">17643436</pub-id></mixed-citation></ref><ref id="B50"><mixed-citation publication-type="journal"><name><surname>Overholt</surname><given-names>BF</given-names></name><name><surname>Panjehpour</surname><given-names>M</given-names></name><name><surname>Halberg</surname><given-names>DL</given-names></name><article-title>Photodynamic therapy for Barrett's esophagus with dysplasia and/or early stage carcinoma: long-term results</article-title><source>Gastrointest Endosc</source><year>2003</year><volume>58</volume><fpage>183</fpage><lpage>188</lpage><pub-id pub-id-type="doi">10.1067/mge.2003.327</pub-id><pub-id pub-id-type="pmid">12872083</pub-id></mixed-citation></ref><ref id="B51"><mixed-citation publication-type="journal"><name><surname>Overholt</surname><given-names>BF</given-names></name><name><surname>Panjehpour</surname><given-names>M</given-names></name><name><surname>Ayres</surname><given-names>M</given-names></name><article-title>Photodynamic therapy for Barrett's esophagus: cardiac effects</article-title><source>Lasers Surg Med</source><year>1997</year><volume>21</volume><fpage>317</fpage><lpage>320</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1096-9101(1997)21:4&#x0003c;317::AID-LSM2&#x0003e;3.0.CO;2-T</pub-id><pub-id pub-id-type="pmid">9328978</pub-id></mixed-citation></ref><ref id="B52"><mixed-citation publication-type="journal"><name><surname>Weiss</surname><given-names>AA</given-names></name><name><surname>Wiesinger</surname><given-names>HAR</given-names></name><name><surname>Owen</surname><given-names>D</given-names></name><article-title>Photodynamic therapy in Barrett's esophagus: Results of treatment of 17 patients</article-title><source>Can J Gastroenterol</source><year>2006</year><volume>20</volume><fpage>261</fpage><lpage>264</lpage><pub-id pub-id-type="pmid">16609754</pub-id></mixed-citation></ref><ref id="B53"><mixed-citation publication-type="journal"><name><surname>Wolfsen</surname><given-names>HC</given-names></name><name><surname>Hemminger</surname><given-names>LL</given-names></name><name><surname>Wallace</surname><given-names>MB</given-names></name><name><surname>DeVault</surname><given-names>KR</given-names></name><article-title>Clinical experience of patients undergoing photodynamic therapy for Barrett's dysplasia or cancer</article-title><source>Aliment Pharmacol Ther</source><year>2004</year><volume>20</volume><fpage>1125</fpage><lpage>1131</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2036.2004.02209.x</pub-id><pub-id pub-id-type="pmid">15569115</pub-id></mixed-citation></ref><ref id="B54"><mixed-citation publication-type="journal"><name><surname>Yachimski</surname><given-names>P</given-names></name><name><surname>Puricelli</surname><given-names>WP</given-names></name><name><surname>Nishioka</surname><given-names>NS</given-names></name><article-title>Patient predictors of esophageal stricture development after photodynamic therapy</article-title><source>Clin Gastroenterol Hepatol</source><year>2008</year><volume>6</volume><fpage>302</fpage><lpage>308</lpage><pub-id pub-id-type="doi">10.1016/j.cgh.2007.12.001</pub-id><pub-id pub-id-type="pmid">18255349</pub-id></mixed-citation></ref><ref id="B55"><mixed-citation publication-type="journal"><name><surname>Thomas</surname><given-names>T</given-names></name><name><surname>Richards</surname><given-names>CJ</given-names></name><name><surname>de Caestecker</surname><given-names>JS</given-names></name><name><surname>Robinson</surname><given-names>RJ</given-names></name><article-title>High-grade dysplasia in Barrett's oesophagus: natural history and review of clinical practice</article-title><source>Aliment Pharmacol Ther</source><year>2005</year><volume>21</volume><fpage>747</fpage><lpage>755</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2036.2005.02401.x</pub-id><pub-id pub-id-type="pmid">15771761</pub-id></mixed-citation></ref><ref id="B56"><mixed-citation publication-type="journal"><name><surname>Attwood</surname><given-names>SE</given-names></name><name><surname>Lewis</surname><given-names>CJ</given-names></name><name><surname>Caplin</surname><given-names>S</given-names></name><name><surname>Hemming</surname><given-names>K</given-names></name><name><surname>Armstrong</surname><given-names>G</given-names></name><article-title>Argon beam plasma coagulation as therapy for high-grade dysplasia in Barrett's esophagus</article-title><source>Clin Gastroenterol Hepatol</source><year>2003</year><volume>1</volume><fpage>258</fpage><lpage>263</lpage><pub-id pub-id-type="doi">10.1016/S1542-3565(03)00128-9</pub-id><pub-id pub-id-type="pmid">15017666</pub-id></mixed-citation></ref><ref id="B57"><mixed-citation publication-type="journal"><name><surname>Basu</surname><given-names>KK</given-names></name><article-title>Effects of low-power argon plasma coagulation thermoablation of Barrett's epithelium on oesophageal motility</article-title><source>Eur J Gastroenterol Hepatol</source><year>2006</year><volume>18</volume><fpage>733</fpage><lpage>737</lpage><pub-id pub-id-type="doi">10.1097/01.meg.0000216928.91618.9a</pub-id><pub-id pub-id-type="pmid">16772830</pub-id></mixed-citation></ref><ref id="B58"><mixed-citation publication-type="journal"><name><surname>Brand</surname><given-names>B</given-names></name><name><surname>Porthun</surname><given-names>M</given-names></name><name><surname>von Schrenck</surname><given-names>T</given-names></name><name><surname>Matsui</surname><given-names>U</given-names></name><name><surname>Bohnacker</surname><given-names>S</given-names></name><name><surname>Jackle</surname><given-names>S</given-names></name><name><surname>Thonke</surname><given-names>F</given-names></name><name><surname>Seitz</surname><given-names>U</given-names></name><name><surname>Soehendra</surname><given-names>N</given-names></name><article-title>Endoscopic Argonplasma coagulation for eradication of Barett's epithelium</article-title><source>Zentralbl Chir</source><year>2000</year><volume>125</volume><fpage>437</fpage><lpage>442</lpage><pub-id pub-id-type="pmid">10929628</pub-id></mixed-citation></ref><ref id="B59"><mixed-citation publication-type="journal"><name><surname>Bright</surname><given-names>T</given-names></name><name><surname>Watson</surname><given-names>DI</given-names></name><name><surname>Tam</surname><given-names>W</given-names></name><name><surname>Game</surname><given-names>PA</given-names></name><name><surname>Astill</surname><given-names>D</given-names></name><name><surname>Ackroyd</surname><given-names>R</given-names></name><name><surname>Wijnhoven</surname><given-names>BP</given-names></name><name><surname>Devitt</surname><given-names>PG</given-names></name><name><surname>Schoeman</surname><given-names>MN</given-names></name><article-title>Randomized trial of argon plasma coagulation versus endoscopic surveillance for barrett esophagus after antireflux surgery: late results</article-title><source>Ann Surg</source><year>2007</year><volume>246</volume><fpage>1016</fpage><lpage>1020</lpage><pub-id pub-id-type="doi">10.1097/SLA.0b013e318133fa85</pub-id><pub-id pub-id-type="pmid">18043104</pub-id></mixed-citation></ref><ref id="B60"><mixed-citation publication-type="journal"><name><surname>Dumoulin</surname><given-names>FL</given-names></name><name><surname>Terjung</surname><given-names>B</given-names></name><name><surname>Neubrand</surname><given-names>M</given-names></name><name><surname>Scheurlen</surname><given-names>C</given-names></name><name><surname>Fischer</surname><given-names>HP</given-names></name><name><surname>Sauerbruch</surname><given-names>T</given-names></name><article-title>Treatment of Barrett's esophagus by endoscopic argon plasma coagulation</article-title><source>Endoscopy</source><year>1997</year><volume>29</volume><fpage>751</fpage><lpage>753</lpage><pub-id pub-id-type="doi">10.1055/s-2007-1004302</pub-id><pub-id pub-id-type="pmid">9427496</pub-id></mixed-citation></ref><ref id="B61"><mixed-citation publication-type="journal"><name><surname>Familiari</surname><given-names>L</given-names></name><article-title>Endoscopic treatment of Barrett's epithelium with Argon Plasma Coagulation. Long-term follow-up</article-title><source>Minerva Gastroenterol Dietol</source><year>2003</year><volume>49</volume><fpage>63</fpage><lpage>70</lpage><pub-id pub-id-type="pmid">16481972</pub-id></mixed-citation></ref><ref id="B62"><mixed-citation publication-type="journal"><name><surname>Ferraris</surname><given-names>R</given-names></name><name><surname>Fracchia</surname><given-names>M</given-names></name><name><surname>Foti</surname><given-names>M</given-names></name><name><surname>Sidoli</surname><given-names>L</given-names></name><name><surname>Taraglio</surname><given-names>S</given-names></name><name><surname>Vigano'</surname><given-names>L</given-names></name><name><surname>Giaccone</surname><given-names>C</given-names></name><name><surname>Rebecchi</surname><given-names>F</given-names></name><name><surname>Meineri</surname><given-names>G</given-names></name><name><surname>Senore</surname><given-names>C</given-names></name><etal/><article-title>Barrett's oesophagus: long-term follow-up after complete ablation with argon plasma coagulation and the factors that determine its recurrence</article-title><source>Aliment Pharmacol Ther</source><year>2007</year><volume>25</volume><fpage>835</fpage><lpage>840</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2036.2007.03251.x</pub-id><pub-id pub-id-type="pmid">17373922</pub-id></mixed-citation></ref><ref id="B63"><mixed-citation publication-type="journal"><name><surname>Formentini</surname><given-names>A</given-names></name><article-title>Treatment of Barrett's esophagus with argon plasma coagulation and antireflux surgery. A retrospective analysis</article-title><source>Hepato-Gastroenterology</source><year>2007</year><volume>54</volume><fpage>1991</fpage><lpage>1996</lpage><pub-id pub-id-type="pmid">18251146</pub-id></mixed-citation></ref><ref id="B64"><mixed-citation publication-type="journal"><name><surname>Grade</surname><given-names>AJ</given-names></name><name><surname>Shah</surname><given-names>IA</given-names></name><name><surname>Medlin</surname><given-names>SM</given-names></name><name><surname>Ramirez</surname><given-names>FC</given-names></name><article-title>The efficacy and safety of argon plasma coagulation therapy in Barrett's esophagus</article-title><source>Gastrointest Endosc</source><year>1999</year><volume>50</volume><fpage>18</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1016/S0016-5107(99)70338-X</pub-id><pub-id pub-id-type="pmid">10385716</pub-id></mixed-citation></ref><ref id="B65"><mixed-citation publication-type="journal"><name><surname>Madisch</surname><given-names>A</given-names></name><name><surname>Miehlke</surname><given-names>S</given-names></name><name><surname>Bayerdorffer</surname><given-names>E</given-names></name><name><surname>Wiedemann</surname><given-names>B</given-names></name><name><surname>Antos</surname><given-names>D</given-names></name><name><surname>Sievert</surname><given-names>A</given-names></name><name><surname>Vieth</surname><given-names>M</given-names></name><name><surname>Stolte</surname><given-names>M</given-names></name><name><surname>Schulz</surname><given-names>H</given-names></name><article-title>Long-term follow-up after complete ablation of Barrett's esophagus with argon plasma coagulation</article-title><source>World J Gastroenterol</source><year>2005</year><volume>11</volume><fpage>1182</fpage><lpage>1186</lpage><pub-id pub-id-type="pmid">15754401</pub-id></mixed-citation></ref><ref id="B66"><mixed-citation publication-type="journal"><name><surname>Manner</surname><given-names>H</given-names></name><name><surname>May</surname><given-names>A</given-names></name><name><surname>Rabenstein</surname><given-names>T</given-names></name><name><surname>Pech</surname><given-names>O</given-names></name><name><surname>Nachbar</surname><given-names>L</given-names></name><name><surname>Enderle</surname><given-names>MD</given-names></name><name><surname>Gossner</surname><given-names>L</given-names></name><name><surname>Ell</surname><given-names>C</given-names></name><article-title>Prospective evaluation of a new high-power argon plasma coagulation system (hp-APC) in therapeutic gastrointestinal endoscopy</article-title><source>Scand J Gastroenterol</source><year>2007</year><volume>42</volume><fpage>397</fpage><lpage>405</lpage><pub-id pub-id-type="doi">10.1080/00365520600898130</pub-id><pub-id pub-id-type="pmid">17354121</pub-id></mixed-citation></ref><ref id="B67"><mixed-citation publication-type="journal"><name><surname>Manner</surname><given-names>H</given-names></name><name><surname>May</surname><given-names>A</given-names></name><name><surname>Faerber</surname><given-names>M</given-names></name><name><surname>Rabenstein</surname><given-names>T</given-names></name><name><surname>Ell</surname><given-names>C</given-names></name><article-title>Safety and efficacy of a new high power argon plasma coagulation system (hp-APC) in lesions of the upper gastrointestinal tract</article-title><source>Dig Liver Dis</source><year>2006</year><volume>38</volume><fpage>471</fpage><lpage>478</lpage><pub-id pub-id-type="doi">10.1016/j.dld.2006.03.022</pub-id><pub-id pub-id-type="pmid">16702032</pub-id></mixed-citation></ref><ref id="B68"><mixed-citation publication-type="journal"><name><surname>Pedrazzani</surname><given-names>C</given-names></name><name><surname>Catalano</surname><given-names>F</given-names></name><name><surname>Festini</surname><given-names>M</given-names></name><name><surname>Zerman</surname><given-names>G</given-names></name><name><surname>Tomezzoli</surname><given-names>A</given-names></name><name><surname>Ruzzenente</surname><given-names>A</given-names></name><name><surname>Guglielmi</surname><given-names>A</given-names></name><name><surname>de</surname><given-names>MG</given-names></name><article-title>Endoscopic ablation of Barrett's esophagus using high power setting argon plasma coagulation: a prospective study</article-title><source>World J Gastroenterol</source><year>2005</year><volume>11</volume><fpage>1872</fpage><lpage>1875</lpage><pub-id pub-id-type="pmid">15793884</pub-id></mixed-citation></ref><ref id="B69"><mixed-citation publication-type="journal"><name><surname>Pereira-Lima</surname><given-names>JC</given-names></name><name><surname>Busnello</surname><given-names>JV</given-names></name><name><surname>Saul</surname><given-names>C</given-names></name><name><surname>Toneloto</surname><given-names>EB</given-names></name><name><surname>Lopes</surname><given-names>CV</given-names></name><name><surname>Rynkowski</surname><given-names>CB</given-names></name><name><surname>Blaya</surname><given-names>C</given-names></name><article-title>High power setting argon plasma coagulation for the eradication of Barrett's esophagus</article-title><source>Am J Gastroenterol</source><year>2000</year><volume>95</volume><fpage>1661</fpage><lpage>1668</lpage><pub-id pub-id-type="doi">10.1111/j.1572-0241.2000.02197.x</pub-id><pub-id pub-id-type="pmid">10925965</pub-id></mixed-citation></ref><ref id="B70"><mixed-citation publication-type="journal"><name><surname>Pinotti</surname><given-names>AC</given-names></name><name><surname>Cecconello</surname><given-names>I</given-names></name><name><surname>Filho</surname><given-names>FM</given-names></name><name><surname>Sakai</surname><given-names>P</given-names></name><name><surname>Gama-Rodrigues</surname><given-names>JJ</given-names></name><name><surname>Pinotti</surname><given-names>HW</given-names></name><article-title>Endoscopic ablation of Barrett's esophagus using argon plasma coagulation: a prospective study after fundoplication</article-title><source>Dis Esophagus</source><year>2004</year><volume>17</volume><fpage>243</fpage><lpage>246</lpage><pub-id pub-id-type="doi">10.1111/j.1442-2050.2004.00415.x</pub-id><pub-id pub-id-type="pmid">15361098</pub-id></mixed-citation></ref><ref id="B71"><mixed-citation publication-type="journal"><name><surname>Tigges</surname><given-names>H</given-names></name><name><surname>Fuchs</surname><given-names>KH</given-names></name><name><surname>Maroske</surname><given-names>J</given-names></name><name><surname>Fein</surname><given-names>M</given-names></name><name><surname>Freys</surname><given-names>SM</given-names></name><name><surname>Muller</surname><given-names>J</given-names></name><name><surname>Thiede</surname><given-names>A</given-names></name><article-title>Combination of endoscopic argon plasma coagulation and antireflux surgery for treatment of Barrett's esophagus</article-title><source>J Gastrointest Surg</source><year>2001</year><volume>5</volume><fpage>251</fpage><lpage>259</lpage><pub-id pub-id-type="doi">10.1016/S1091-255X(01)80045-7</pub-id><pub-id pub-id-type="pmid">11360048</pub-id></mixed-citation></ref><ref id="B72"><mixed-citation publication-type="journal"><name><surname>Van Laethem</surname><given-names>JL</given-names></name><name><surname>Jagodzinski</surname><given-names>R</given-names></name><name><surname>Peny</surname><given-names>MO</given-names></name><name><surname>Cremer</surname><given-names>M</given-names></name><name><surname>Deviere</surname><given-names>J</given-names></name><article-title>Argon plasma coagulation in the treatment of Barrett's high-grade dysplasia and in situ adenocarcinoma</article-title><source>Endoscopy</source><year>2001</year><volume>33</volume><fpage>257</fpage><lpage>261</lpage><pub-id pub-id-type="doi">10.1055/s-2001-12803</pub-id><pub-id pub-id-type="pmid">11293760</pub-id></mixed-citation></ref><ref id="B73"><mixed-citation publication-type="journal"><name><surname>Van Laethem</surname><given-names>JL</given-names></name><name><surname>Cremer</surname><given-names>M</given-names></name><name><surname>Peny</surname><given-names>MO</given-names></name><name><surname>Delhaye</surname><given-names>M</given-names></name><name><surname>Deviere</surname><given-names>J</given-names></name><article-title>Eradication of Barrett's mucosa with argon plasma coagulation and acid suppression: immediate and mid term results</article-title><source>Gut</source><year>1998</year><volume>43</volume><fpage>747</fpage><lpage>751</lpage><pub-id pub-id-type="doi">10.1136/gut.43.6.747</pub-id><pub-id pub-id-type="pmid">9824599</pub-id></mixed-citation></ref><ref id="B74"><mixed-citation publication-type="other"><name><surname>Dumot</surname><given-names>JA</given-names></name><name><surname>Vargo</surname><given-names>JJ</given-names></name><name><surname>Zuccaro</surname><given-names>G</given-names></name><name><surname>Falk</surname><given-names>GW</given-names></name><name><surname>Frey</surname><given-names>L</given-names></name><name><surname>Rice</surname><given-names>T</given-names></name><article-title>Results of cryospray ablation for esophageal high grade dysplasia (HGD) and intramucosal cancer (Imca) in high risk non-surgical patients [abstract]</article-title><source>Digestive Disease Week</source><year>2008</year><fpage>M1304</fpage></mixed-citation></ref><ref id="B75"><mixed-citation publication-type="journal"><name><surname>Johnston</surname><given-names>MH</given-names></name><article-title>Cryoablation of Barrett's esophagus: A pilot study</article-title><source>Gastrointest Endosc</source><year>2005</year><volume>62</volume><fpage>842</fpage><lpage>848</lpage><pub-id pub-id-type="doi">10.1016/j.gie.2005.05.008</pub-id><pub-id pub-id-type="pmid">16301023</pub-id></mixed-citation></ref><ref id="B76"><mixed-citation publication-type="journal"><name><surname>Wolfsen</surname><given-names>HC</given-names></name><name><surname>Hemminger</surname><given-names>LL</given-names></name><name><surname>Raimondo</surname><given-names>M</given-names></name><name><surname>Woodward</surname><given-names>TA</given-names></name><article-title>Photodynamic therapy and endoscopic mucosal resection for Barrett's dysplasia and early esophageal adenocarcinoma</article-title><source>South Med J</source><year>2004</year><volume>97</volume><fpage>827</fpage><lpage>830</lpage><pub-id pub-id-type="doi">10.1097/01.SMJ.0000136265.34296.62</pub-id><pub-id pub-id-type="pmid">15455964</pub-id></mixed-citation></ref><ref id="B77"><mixed-citation publication-type="journal"><name><surname>Michopoulos</surname><given-names>S</given-names></name><name><surname>Tsibouris</surname><given-names>P</given-names></name><name><surname>Bouzakis</surname><given-names>H</given-names></name><name><surname>Sotiropoulou</surname><given-names>M</given-names></name><name><surname>Kralios</surname><given-names>N</given-names></name><article-title>Complete regression of Barrett's esophagus with heat probe thermocoagulation: mid-term results</article-title><source>Gastrointest Endosc</source><year>1999</year><volume>50</volume><fpage>165</fpage><lpage>172</lpage><pub-id pub-id-type="doi">10.1016/S0016-5107(99)70219-1</pub-id><pub-id pub-id-type="pmid">10425407</pub-id></mixed-citation></ref><ref id="B78"><mixed-citation publication-type="journal"><name><surname>Giovannini</surname><given-names>M</given-names></name><name><surname>Bories</surname><given-names>E</given-names></name><name><surname>Pesenti</surname><given-names>C</given-names></name><name><surname>Moutardier</surname><given-names>V</given-names></name><name><surname>Monges</surname><given-names>G</given-names></name><name><surname>Danisi</surname><given-names>C</given-names></name><name><surname>Lelong</surname><given-names>B</given-names></name><name><surname>Delpero</surname><given-names>JR</given-names></name><article-title>Circumferential endoscopic mucosal resection in Barrett's esophagus with high-grade intraepithelial neoplasia or mucosal cancer. Preliminary results in 21 patients</article-title><source>Endoscopy</source><year>2004</year><volume>36</volume><fpage>782</fpage><lpage>787</lpage><pub-id pub-id-type="doi">10.1055/s-2004-825813</pub-id><pub-id pub-id-type="pmid">15326573</pub-id></mixed-citation></ref><ref id="B79"><mixed-citation publication-type="journal"><name><surname>Mino-Kenudson</surname><given-names>M</given-names></name><name><surname>Brugge</surname><given-names>WR</given-names></name><name><surname>Puricelli</surname><given-names>WP</given-names></name><name><surname>Nakatsuka</surname><given-names>LN</given-names></name><name><surname>Nishioka</surname><given-names>NS</given-names></name><name><surname>Zukerberg</surname><given-names>LR</given-names></name><name><surname>Misdraji</surname><given-names>J</given-names></name><name><surname>Lauwers</surname><given-names>GY</given-names></name><article-title>Management of superficial Barrett's epithelium-related neoplasms by endoscopic mucosal resection - Clinicopathologic analysis of 27 cases</article-title><source>Am J Surg Pathol</source><year>2005</year><volume>29</volume><fpage>680</fpage><lpage>686</lpage><pub-id pub-id-type="doi">10.1097/01.pas.0000154129.87219.fa</pub-id><pub-id pub-id-type="pmid">15832094</pub-id></mixed-citation></ref><ref id="B80"><mixed-citation publication-type="journal"><name><surname>Seewald</surname><given-names>S</given-names></name><name><surname>Akaraviputh</surname><given-names>T</given-names></name><name><surname>Seitz</surname><given-names>U</given-names></name><name><surname>Brand</surname><given-names>B</given-names></name><name><surname>Groth</surname><given-names>S</given-names></name><name><surname>Mendoza</surname><given-names>G</given-names></name><name><surname>He</surname><given-names>XK</given-names></name><name><surname>Thonke</surname><given-names>F</given-names></name><name><surname>Stolte</surname><given-names>M</given-names></name><name><surname>Schroeder</surname><given-names>S</given-names></name><etal/><article-title>Circumferential EMR and complete removal of Barrett's epithelium: a new approach to management of Barrett's esophagus containing high-grade intraepithelial neoplasia and intramucosal carcinoma</article-title><source>Gastrointest Endosc</source><year>2003</year><volume>57</volume><fpage>854</fpage><lpage>859</lpage><pub-id pub-id-type="doi">10.1016/S0016-5107(03)70020-0</pub-id><pub-id pub-id-type="pmid">12776032</pub-id></mixed-citation></ref><ref id="B81"><mixed-citation publication-type="journal"><name><surname>Tang</surname><given-names>SJ</given-names></name><name><surname>Tang</surname><given-names>L</given-names></name><name><surname>Jazrawi</surname><given-names>SF</given-names></name><article-title>Circumferential endoscopic mucosal resection of a 14-cm Barrett's dysplasia with the Duette mucosectomy device (with videos)</article-title><source>Gastrointest Endosc</source><year>2008</year><volume>68</volume><fpage>786</fpage><lpage>789</lpage><pub-id pub-id-type="doi">10.1016/j.gie.2008.01.018</pub-id><pub-id pub-id-type="pmid">18455171</pub-id></mixed-citation></ref><ref id="B82"><mixed-citation publication-type="journal"><name><surname>Barham</surname><given-names>CP</given-names></name><name><surname>Jones</surname><given-names>RL</given-names></name><name><surname>Biddlestone</surname><given-names>LR</given-names></name><name><surname>Hardwick</surname><given-names>RH</given-names></name><name><surname>Shepherd</surname><given-names>NA</given-names></name><name><surname>Barr</surname><given-names>H</given-names></name><article-title>Photothermal laser ablation of Barrett's oesophagus: endoscopic and histological evidence of squamous re-epithelialisation</article-title><source>Gut</source><year>1997</year><volume>41</volume><fpage>281</fpage><lpage>284</lpage><pub-id pub-id-type="doi">10.1136/gut.41.3.281</pub-id><pub-id pub-id-type="pmid">9378378</pub-id></mixed-citation></ref><ref id="B83"><mixed-citation publication-type="journal"><name><surname>Bonavina</surname><given-names>L</given-names></name><name><surname>Ceriani</surname><given-names>C</given-names></name><name><surname>Carazzone</surname><given-names>A</given-names></name><name><surname>Segalin</surname><given-names>A</given-names></name><name><surname>Ferrero</surname><given-names>S</given-names></name><name><surname>Peracchia</surname><given-names>A</given-names></name><article-title>Endoscopic laser ablation of nondysplastic Barrett's epithelium: Is it worthwhile?</article-title><source>J Gastrointest Surg</source><year>1999</year><volume>3</volume><fpage>194</fpage><lpage>198</lpage><pub-id pub-id-type="doi">10.1016/S1091-255X(99)80033-X</pub-id><pub-id pub-id-type="pmid">10457346</pub-id></mixed-citation></ref><ref id="B84"><mixed-citation publication-type="journal"><name><surname>Bowers</surname><given-names>SP</given-names></name><name><surname>Mattar</surname><given-names>SG</given-names></name><name><surname>Waring</surname><given-names>PJ</given-names></name><name><surname>Galloway</surname><given-names>K</given-names></name><name><surname>Nasir</surname><given-names>A</given-names></name><name><surname>Pascal</surname><given-names>R</given-names></name><name><surname>Hunter</surname><given-names>JG</given-names></name><article-title>KTP laser ablation of Barrett's esophagus after anti-reflux surgery results in long-term loss of intestinal metaplasia. Potassium-titanyl-phosphate</article-title><source>Surg Endosc</source><year>2003</year><volume>17</volume><fpage>49</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.1007/s00464-001-8155-1</pub-id><pub-id pub-id-type="pmid">12364985</pub-id></mixed-citation></ref><ref id="B85"><mixed-citation publication-type="journal"><name><surname>Ertan</surname><given-names>A</given-names></name><name><surname>Zimmerman</surname><given-names>M</given-names></name><name><surname>Younes</surname><given-names>M</given-names></name><article-title>Esophageal adenocarcinoma associated with Barretts esophagus - long-term management with laser-ablation</article-title><source>Am J Gastroenterol</source><year>1995</year><volume>90</volume><fpage>2201</fpage><lpage>2203</lpage><pub-id pub-id-type="pmid">8540516</pub-id></mixed-citation></ref><ref id="B86"><mixed-citation publication-type="journal"><name><surname>Norberto</surname><given-names>L</given-names></name><name><surname>Polese</surname><given-names>L</given-names></name><name><surname>Angriman</surname><given-names>I</given-names></name><name><surname>Erroi</surname><given-names>F</given-names></name><name><surname>Cecchetto</surname><given-names>A</given-names></name><name><surname>D'Amico</surname><given-names>DF</given-names></name><article-title>High-energy laser therapy of Barrett's esophagus: Preliminary results</article-title><source>World J Surg</source><year>2004</year><volume>28</volume><fpage>350</fpage><lpage>354</lpage><pub-id pub-id-type="doi">10.1007/s00268-003-7332-x</pub-id><pub-id pub-id-type="pmid">15022019</pub-id></mixed-citation></ref><ref id="B87"><mixed-citation publication-type="journal"><name><surname>Salo</surname><given-names>JA</given-names></name><name><surname>Salminen</surname><given-names>JT</given-names></name><name><surname>Kiviluoto</surname><given-names>TA</given-names></name><name><surname>Nemlander</surname><given-names>AT</given-names></name><name><surname>Ramo</surname><given-names>OJ</given-names></name><name><surname>Farkkila</surname><given-names>MA</given-names></name><name><surname>Kivilaakso</surname><given-names>EO</given-names></name><name><surname>Mattila</surname><given-names>SP</given-names></name><article-title>Treatment of Barrett's esophagus by endoscopic laser ablation and antireflux surgery</article-title><source>Ann Surg</source><year>1998</year><volume>227</volume><fpage>40</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.1097/00000658-199801000-00006</pub-id><pub-id pub-id-type="pmid">9445108</pub-id></mixed-citation></ref><ref id="B88"><mixed-citation publication-type="journal"><name><surname>Faigel</surname><given-names>DO</given-names></name><name><surname>Lieberman</surname><given-names>DA</given-names></name><name><surname>Weinstein</surname><given-names>WM</given-names></name><name><surname>Fanning</surname><given-names>S</given-names></name><name><surname>Fennerty</surname><given-names>MB</given-names></name><name><surname>Sampliner</surname><given-names>RB</given-names></name><article-title>Effect of multipolar electrocoagulation on EUS findings in Barrett's esophagus</article-title><source>Gastrointest Endosc</source><year>2002</year><volume>55</volume><fpage>23</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1067/mge.2002.120100</pub-id><pub-id pub-id-type="pmid">11756909</pub-id></mixed-citation></ref><ref id="B89"><mixed-citation publication-type="journal"><name><surname>Kovacs</surname><given-names>BJ</given-names></name><name><surname>Chen</surname><given-names>YK</given-names></name><name><surname>Lewis</surname><given-names>TD</given-names></name><name><surname>DeGuzman</surname><given-names>LJ</given-names></name><name><surname>Thompson</surname><given-names>KS</given-names></name><article-title>Successful reversal of Barrett's esophagus with multipolar electrocoagulation despite inadequate acid suppression</article-title><source>Gastrointest Endosc</source><year>1999</year><volume>49</volume><fpage>547</fpage><lpage>553</lpage><pub-id pub-id-type="doi">10.1016/S0016-5107(99)70380-9</pub-id><pub-id pub-id-type="pmid">10228250</pub-id></mixed-citation></ref><ref id="B90"><mixed-citation publication-type="journal"><name><surname>Montes</surname><given-names>CG</given-names></name><name><surname>Brandalise</surname><given-names>NA</given-names></name><name><surname>Deliza</surname><given-names>R</given-names></name><name><surname>de Magalhaes</surname><given-names>AFN</given-names></name><name><surname>Ferraz</surname><given-names>JGP</given-names></name><article-title>Antireflux surgery followed by bipolar electrocoagulation in the treatment of Barrett's esophagus</article-title><source>Gastrointest Endosc</source><year>1999</year><volume>50</volume><fpage>173</fpage><lpage>177</lpage><pub-id pub-id-type="doi">10.1016/S0016-5107(99)70220-8</pub-id><pub-id pub-id-type="pmid">10425408</pub-id></mixed-citation></ref><ref id="B91"><mixed-citation publication-type="journal"><name><surname>Sampliner</surname><given-names>RE</given-names></name><name><surname>Fennerty</surname><given-names>B</given-names></name><name><surname>Garewal</surname><given-names>HS</given-names></name><article-title>Reversal of Barrett's esophagus with acid suppression and multipolar electrocoagulation: Preliminary results</article-title><source>Gastrointest Endosc</source><year>1996</year><volume>44</volume><fpage>532</fpage><lpage>535</lpage><pub-id pub-id-type="doi">10.1016/S0016-5107(96)70004-4</pub-id><pub-id pub-id-type="pmid">8934157</pub-id></mixed-citation></ref><ref id="B92"><mixed-citation publication-type="journal"><name><surname>Bumgarner</surname><given-names>JM</given-names></name><name><surname>Panjehpour</surname><given-names>M</given-names></name><name><surname>Long</surname><given-names>M</given-names></name><name><surname>Dellon</surname><given-names>ES</given-names></name><name><surname>Overholt</surname><given-names>BF</given-names></name><name><surname>Shaheen</surname><given-names>NJ</given-names></name><article-title>Comparison of catheter-based radiofrequency ablation and photodynamic therapy for Barrett's esophagus [abstract]</article-title><source>Gastroenterology</source><year>2008</year><volume>134</volume><fpage>A436</fpage><pub-id pub-id-type="doi">10.1016/S0016-5085(08)62035-1</pub-id></mixed-citation></ref><ref id="B93"><mixed-citation publication-type="journal"><name><surname>Eldaif</surname><given-names>SM</given-names></name><name><surname>Lin</surname><given-names>E</given-names></name><name><surname>Singh</surname><given-names>KA</given-names></name><name><surname>Force</surname><given-names>SD</given-names></name><name><surname>Miller</surname><given-names>DL</given-names></name><article-title>Radiofrequency ablation of Barrett's esophagus: short-term results</article-title><source>Ann Thorac Surg</source><year>2009</year><volume>87</volume><fpage>405</fpage><lpage>410</lpage><pub-id pub-id-type="doi">10.1016/j.athoracsur.2008.11.043</pub-id><pub-id pub-id-type="pmid">19161747</pub-id></mixed-citation></ref><ref id="B94"><mixed-citation publication-type="journal"><name><surname>Fleischer</surname><given-names>DE</given-names></name><name><surname>Overholt</surname><given-names>BF</given-names></name><name><surname>Sharma</surname><given-names>VK</given-names></name><name><surname>Reymunde</surname><given-names>A</given-names></name><name><surname>Kimmey</surname><given-names>MB</given-names></name><name><surname>Chuttani</surname><given-names>R</given-names></name><name><surname>Chang</surname><given-names>KJ</given-names></name><name><surname>Lightdale</surname><given-names>CJ</given-names></name><name><surname>Santiago</surname><given-names>N</given-names></name><name><surname>Pleskow</surname><given-names>DK</given-names></name><etal/><article-title>Endoscopic ablation of Barrett's esophagus: a multicenter study with 2.5-year follow-up</article-title><source>Gastrointest Endosc</source><year>2008</year><volume>68</volume><fpage>867</fpage><lpage>876</lpage><pub-id pub-id-type="doi">10.1016/j.gie.2008.03.008</pub-id><pub-id pub-id-type="pmid">18561930</pub-id></mixed-citation></ref><ref id="B95"><mixed-citation publication-type="journal"><name><surname>Ganz</surname><given-names>RA</given-names></name><name><surname>Overholt</surname><given-names>BF</given-names></name><name><surname>Sharma</surname><given-names>VK</given-names></name><name><surname>Fleischer</surname><given-names>DE</given-names></name><name><surname>Shaheen</surname><given-names>NJ</given-names></name><name><surname>Lightdale</surname><given-names>CJ</given-names></name><name><surname>Freeman</surname><given-names>SR</given-names></name><name><surname>Pruitt</surname><given-names>RE</given-names></name><name><surname>Urayama</surname><given-names>SM</given-names></name><name><surname>Gress</surname><given-names>F</given-names></name><etal/><article-title>Circumferential ablation of Barrett's esophagus that contains high-grade dysplasia: a U.S. Multicenter Registry</article-title><source>Gastrointest Endosc</source><year>2008</year><volume>68</volume><fpage>35</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.1016/j.gie.2007.12.015</pub-id><pub-id pub-id-type="pmid">18355819</pub-id></mixed-citation></ref><ref id="B96"><mixed-citation publication-type="journal"><name><surname>Hernandez</surname><given-names>JC</given-names></name><name><surname>Reicher</surname><given-names>S</given-names></name><name><surname>Chung</surname><given-names>D</given-names></name><name><surname>Pham</surname><given-names>BV</given-names></name><name><surname>Tsai</surname><given-names>F</given-names></name><name><surname>Disibio</surname><given-names>G</given-names></name><name><surname>French</surname><given-names>S</given-names></name><name><surname>Eysselein</surname><given-names>VE</given-names></name><article-title>Pilot series of radiofrequency ablation of Barrett's esophagus with or without neoplasia</article-title><source>Endoscopy</source><year>2008</year><volume>40</volume><fpage>388</fpage><lpage>392</lpage><pub-id pub-id-type="doi">10.1055/s-2007-995747</pub-id><pub-id pub-id-type="pmid">18459075</pub-id></mixed-citation></ref><ref id="B97"><mixed-citation publication-type="journal"><name><surname>Hubbard</surname><given-names>N</given-names></name><name><surname>Velanovich</surname><given-names>V</given-names></name><article-title>Endoscopic endoluminal radiofrequency ablation of Barrett's esophagus in patients with fundoplications</article-title><source>Surg Endosc</source><year>2007</year><volume>21</volume><fpage>625</fpage><lpage>628</lpage><pub-id pub-id-type="doi">10.1007/s00464-007-9199-7</pub-id><pub-id pub-id-type="pmid">17364152</pub-id></mixed-citation></ref><ref id="B98"><mixed-citation publication-type="journal"><name><surname>Pouw</surname><given-names>RE</given-names></name><name><surname>Gondrie</surname><given-names>JJ</given-names></name><name><surname>Sondermeijer</surname><given-names>CM</given-names></name><name><surname>Ten Kate</surname><given-names>FJ</given-names></name><name><surname>van Gulik</surname><given-names>TM</given-names></name><name><surname>Krishnadath</surname><given-names>KK</given-names></name><name><surname>Fockens</surname><given-names>P</given-names></name><name><surname>Weusten</surname><given-names>BL</given-names></name><name><surname>Bergman</surname><given-names>JJ</given-names></name><article-title>Eradication of Barrett esophagus with early neoplasia by radiofrequency ablation, with or without endoscopic resection</article-title><source>J Gastrointest Surg</source><year>2008</year><volume>12</volume><fpage>1627</fpage><lpage>1636</lpage><pub-id pub-id-type="doi">10.1007/s11605-008-0629-1</pub-id><pub-id pub-id-type="pmid">18704598</pub-id></mixed-citation></ref><ref id="B99"><mixed-citation publication-type="journal"><name><surname>Roorda</surname><given-names>AK</given-names></name><name><surname>Marcus</surname><given-names>SN</given-names></name><name><surname>Triadafilopoulos</surname><given-names>G</given-names></name><article-title>Early experience with radiofrequency energy ablation therapy for Barrett's esophagus with and without dysplasia</article-title><source>Dis Esophagus</source><year>2007</year><volume>20</volume><fpage>516</fpage><lpage>522</lpage><pub-id pub-id-type="doi">10.1111/j.1442-2050.2007.00728.x</pub-id><pub-id pub-id-type="pmid">17958728</pub-id></mixed-citation></ref><ref id="B100"><mixed-citation publication-type="journal"><name><surname>Sharma</surname><given-names>VK</given-names></name><name><surname>Wang</surname><given-names>KK</given-names></name><name><surname>Overholt</surname><given-names>BF</given-names></name><name><surname>Lightdale</surname><given-names>CJ</given-names></name><name><surname>Fennerty</surname><given-names>MB</given-names></name><name><surname>Dean</surname><given-names>PJ</given-names></name><name><surname>Pleskow</surname><given-names>DK</given-names></name><name><surname>Chuttani</surname><given-names>R</given-names></name><name><surname>Reymunde</surname><given-names>A</given-names></name><name><surname>Santiago</surname><given-names>N</given-names></name><etal/><article-title>Balloon-based, circumferential, endoscopic radiofrequency ablation of Barrett's esophagus: 1-year follow-up of 100 patients</article-title><source>Gastrointest Endosc</source><year>2007</year><volume>65</volume><fpage>185</fpage><lpage>195</lpage><pub-id pub-id-type="doi">10.1016/j.gie.2006.09.033</pub-id><pub-id pub-id-type="pmid">17258973</pub-id></mixed-citation></ref><ref id="B101"><mixed-citation publication-type="journal"><name><surname>Smith</surname><given-names>CD</given-names></name><name><surname>Bejarano</surname><given-names>PA</given-names></name><name><surname>Melvin</surname><given-names>WS</given-names></name><name><surname>Patti</surname><given-names>MG</given-names></name><name><surname>Muthusamy</surname><given-names>R</given-names></name><name><surname>Dunkin</surname><given-names>BJ</given-names></name><article-title>Endoscopic ablation of intestinal metaplasia containing high-grade dysplasia in esophagectomy patients using a balloon-based ablation system</article-title><source>Surg Endosc</source><year>2007</year><volume>21</volume><fpage>560</fpage><lpage>569</lpage><pub-id pub-id-type="doi">10.1007/s00464-006-9053-3</pub-id><pub-id pub-id-type="pmid">17180281</pub-id></mixed-citation></ref><ref id="B102"><mixed-citation publication-type="journal"><name><surname>Sharma</surname><given-names>VK</given-names></name><name><surname>Jae</surname><given-names>KH</given-names></name><name><surname>Das</surname><given-names>A</given-names></name><name><surname>Wells</surname><given-names>CD</given-names></name><name><surname>Nguyen</surname><given-names>CC</given-names></name><name><surname>Fleischer</surname><given-names>DE</given-names></name><article-title>Circumferential and focal ablation of Barrett's esophagus containing dysplasia</article-title><source>Am J Gastroenterol</source><year>2009</year><volume>104</volume><fpage>310</fpage><lpage>317</lpage><pub-id pub-id-type="doi">10.1038/ajg.2008.142</pub-id><pub-id pub-id-type="pmid">19174783</pub-id></mixed-citation></ref><ref id="B103"><mixed-citation publication-type="other"><name><surname>Vassiliou</surname><given-names>MC</given-names></name><name><surname>von</surname><given-names>RD</given-names></name><name><surname>Wiener</surname><given-names>DC</given-names></name><name><surname>Gordon</surname><given-names>SR</given-names></name><name><surname>Rothstein</surname><given-names>RI</given-names></name><article-title>Treatment of ultralong-segment Barrett's using focal and balloon-based radiofrequency ablation</article-title><source>Surg Endosc</source><year>2009</year></mixed-citation></ref><ref id="B104"><mixed-citation publication-type="journal"><name><surname>Velanovich</surname><given-names>V</given-names></name><article-title>Endoscopic endoluminal radiofrequency ablation of Barrett's esophagus: initial results and lessons learned</article-title><source>Surg Endosc</source><year>2009</year><volume>23</volume><fpage>2175</fpage><lpage>2180</lpage><pub-id pub-id-type="doi">10.1007/s00464-009-0364-z</pub-id><pub-id pub-id-type="pmid">19263139</pub-id></mixed-citation></ref><ref id="B105"><mixed-citation publication-type="journal"><name><surname>Gondrie</surname><given-names>JJ</given-names></name><name><surname>Pouw</surname><given-names>RE</given-names></name><name><surname>Sondermeijer</surname><given-names>CMT</given-names></name><name><surname>Peters</surname><given-names>FP</given-names></name><name><surname>Curvers</surname><given-names>WL</given-names></name><name><surname>Rosmolen</surname><given-names>WD</given-names></name><name><surname>Krishnadath</surname><given-names>KK</given-names></name><name><surname>Ten Kate</surname><given-names>F</given-names></name><name><surname>Fockens</surname><given-names>P</given-names></name><name><surname>Bergman</surname><given-names>JJ</given-names></name><article-title>Stepwise circumferential and focal ablation of Barrett's esophagus with high-grade dysplasia: results of the first prospective series of 11 patients</article-title><source>Endoscopy</source><year>2008</year><volume>40</volume><fpage>359</fpage><lpage>369</lpage><pub-id pub-id-type="doi">10.1055/s-2007-995567</pub-id><pub-id pub-id-type="pmid">18494131</pub-id></mixed-citation></ref><ref id="B106"><mixed-citation publication-type="journal"><name><surname>Gondrie</surname><given-names>JJ</given-names></name><name><surname>Pouw</surname><given-names>RE</given-names></name><name><surname>Sondermeijer</surname><given-names>CM</given-names></name><name><surname>Peters</surname><given-names>FP</given-names></name><name><surname>Curvers</surname><given-names>WL</given-names></name><name><surname>Rosmolen</surname><given-names>WD</given-names></name><name><surname>ten</surname><given-names>KF</given-names></name><name><surname>Fockens</surname><given-names>P</given-names></name><name><surname>Bergman</surname><given-names>JJ</given-names></name><article-title>Effective treatment of early Barrett's neoplasia with stepwise circumferential and focal ablation using the HALO system</article-title><source>Endoscopy</source><year>2008</year><volume>40</volume><fpage>370</fpage><lpage>379</lpage><pub-id pub-id-type="doi">10.1055/s-2007-995589</pub-id><pub-id pub-id-type="pmid">18494132</pub-id></mixed-citation></ref><ref id="B107"><mixed-citation publication-type="journal"><name><surname>Ferguson</surname><given-names>MK</given-names></name><name><surname>Naunheim</surname><given-names>KS</given-names></name><article-title>Resection for Barrett's mucosa with high-grade dysplasia: implications for prophylactic photodynamic therapy</article-title><source>J Thorac Cardiovasc Surg</source><year>1997</year><volume>114</volume><fpage>824</fpage><lpage>829</lpage><pub-id pub-id-type="doi">10.1016/S0022-5223(97)70087-4</pub-id><pub-id pub-id-type="pmid">9375613</pub-id></mixed-citation></ref><ref id="B108"><mixed-citation publication-type="journal"><name><surname>Nguyen</surname><given-names>NT</given-names></name><name><surname>Schauer</surname><given-names>P</given-names></name><name><surname>Luketich</surname><given-names>JD</given-names></name><article-title>Minimally invasive esophagectomy for Barrett's esophagus with high-grade dysplasia</article-title><source>Surgery</source><year>2000</year><volume>127</volume><fpage>284</fpage><lpage>290</lpage><pub-id pub-id-type="doi">10.1067/msy.2000.103489</pub-id><pub-id pub-id-type="pmid">10715983</pub-id></mixed-citation></ref><ref id="B109"><mixed-citation publication-type="journal"><name><surname>Romagnoli</surname><given-names>R</given-names></name><article-title>Outcomes of dysplasia arising in Barrett's esophagus: A dynamic view</article-title><source>J Am Coll Surg</source><year>2003</year><volume>197</volume><fpage>365</fpage><lpage>371</lpage><pub-id pub-id-type="doi">10.1016/S1072-7515(03)00417-4</pub-id><pub-id pub-id-type="pmid">12946790</pub-id></mixed-citation></ref><ref id="B110"><mixed-citation publication-type="journal"><name><surname>Sujendran</surname><given-names>V</given-names></name><name><surname>Sica</surname><given-names>G</given-names></name><name><surname>Warren</surname><given-names>B</given-names></name><name><surname>Maynard</surname><given-names>N</given-names></name><article-title>Oesophagectomy remains the gold standard for treatment of high-grade dysplasia in Barrett's oesophagus</article-title><source>Eur J Cardiothorac Surg</source><year>2005</year><volume>28</volume><fpage>763</fpage><lpage>766</lpage><pub-id pub-id-type="doi">10.1016/j.ejcts.2005.08.018</pub-id><pub-id pub-id-type="pmid">16188449</pub-id></mixed-citation></ref><ref id="B111"><mixed-citation publication-type="journal"><name><surname>Thomson</surname><given-names>BNJ</given-names></name><name><surname>Cade</surname><given-names>RJ</given-names></name><article-title>Oesophagectomy for early adenocarcinoma and dysplasia arising in Barrett's oesophagus</article-title><source>ANZ J Surg</source><year>2003</year><volume>73</volume><fpage>121</fpage><lpage>124</lpage><pub-id pub-id-type="doi">10.1046/j.1445-2197.2003.02646.x</pub-id><pub-id pub-id-type="pmid">12608973</pub-id></mixed-citation></ref></ref-list></back></article>